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A B S T R A C T
Background
Despite medical therapies and surgical interventions for Parkinson’s disease (PD), patients develop progressive disability. The role of
physiotherapy is tomaximise functional ability andminimise secondary complications throughmovement rehabilitationwithin a context
of education and support for the whole person. The overall aim is to optimise independence, safety and wellbeing, thereby enhancing
quality of life. Trials have shown that physiotherapy has short-term benefits in PD. However, which physiotherapy intervention is most
effective remains unclear.
Objectives
To assess the effectiveness of one physiotherapy intervention compared with a second approach in patients with PD.
Search methods
Relevant trials were identified by electronic searches of numerous literature databases (for example MEDLINE, EMBASE) and trial
registers, plus handsearching of major journals, abstract books, conference proceedings and reference lists of retrieved publications. The
literature search included trials published up to the end of January 2012.
Selection criteria
Randomised controlled trials of one physiotherapy intervention versus another physiotherapy intervention in patients with PD.
Data collection and analysis
Data were abstracted independently from each paper by two authors. Trials were classified into the following intervention comparisons:
general physiotherapy, exercise, treadmill training, cueing, dance and martial arts.
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Main results
A total of 43 trials were identified with 1673 participants. All trials used small patient numbers (average trial size of 39 participants);
the methods of randomisation and concealment of allocation were poor or not stated in most trials. Blinded assessors were used in just
over half of the trials and only 10 stated that they used intention-to-treat analysis.
A wide variety of validated and customised outcome measures were used to assess the effectiveness of physiotherapy interventions. The
most frequently reported physiotherapy outcomes were gait speed and timed up and go, in 19 and 15 trials respectively. Only five of
the 43 trials reported data on falls (12%). The motor subscales of the Unified Parkinson’s Disease Rating Scale and Parkinson’s Disease
Questionnaire-39 were the most commonly reported clinician-rated disability and patient-rated quality of life outcome measures, used
in 22 and 13 trials respectively. The content and delivery of the physiotherapy interventions varied widely in the trials included within
this review, so no quantitative meta-analysis could be performed.
Authors’ conclusions
Considering the small number of participants examined, the methodological flaws in many of the studies, the possibility of publication
bias, and the variety of interventions, formal comparison of the different physiotherapy techniques could not be performed. There is
insufficient evidence to support or refute the effectiveness of one physiotherapy intervention over another in PD.
This review shows that a wide range of physiotherapy interventions to treat PD have been tested . There is a need for more specific
trials with improved treatment strategies to underpin the most appropriate choice of physiotherapy intervention and the outcomes
measured.
P L A I N L A N G U A G E S U M M A R Y
Physiotherapy for the treatment of Parkinson’s disease
In spite of various medical and surgical treatments for Parkinson’s disease (PD) patients gradually develop significant physical problems.
Physiotherapists aim to enable people with PD to maintain their maximum level of mobility, activity and independence through the
provision of the appropriate treatment. A range of approaches to movement rehabilitation are used, which aim to enhance quality of
life by maximising physical ability and minimising secondary complications over the whole course of the disease. Evidence has shown
that physiotherapy has short-term benefits in PD, however which approach of physiotherapy is most effective remains unclear.
Only randomised controlled trials were included in this review. These were studies where a group of participants were given one
physiotherapy intervention andwere comparedwith another groupwho received a different physiotherapy intervention.The participants
were assigned to a group in a random fashion to reduce the potential for bias.
A total of 43 randomised trials involving 1673 participants (average trial size of just 39 participants) were identified as suitable for this
review. The trials assessed various physiotherapy interventions, so they were grouped according to the type of intervention being used
(general physiotherapy, exercise, treadmill training, cueing, dance or martial arts). However, despite this grouping, the physiotherapy
interventions delivered and the outcomes assessed varied so much that the results of the individual trials could not be combined.
This review highlights that a wide range of different physiotherapy techniques have been tested to treat PD. Considering the small
number of participants, the wide variety of physiotherapy interventions and the outcomes assessed, there is insufficient evidence to
support the use of one approach of physiotherapy intervention over another for the treatment of PD.
B A C K G R O U N D
Parkinson’s disease (PD) is a complex neurodegenerative disorder
(Rubenis 2007) with wide reaching implications for patients and
their families. Whilst disability can occur at all stages of the disease
(Deane 2001a), PD is progressive in nature. Patients face increased
difficulties with activities of daily living (ADL) (Kwakkel 2007)
and mobility such as gait, transfers, balance and posture (Keus
2007). Ultimately this leads to decreased independence, inactivity
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and social isolation (Keus 2007), resulting in reduced quality of
life (Schrag 2000).
The management of PD has traditionally centred on drug ther-
apy with levodopa viewed as the ’gold standard’ treatment (Rascol
2002). However, even with optimal medical management, pa-
tients with PD still experience a deterioration of body function,
daily activities and participation (Nijkrake 2007). For this reason
there has been increasing support for the inclusion of rehabilita-
tion therapies as an adjuvant to pharmacological and neurosurgi-
cal treatment (Gage 2004; Nijkrake 2007) and a call for the move
towards multidisciplinary management of this multidimensional
condition (Robertson 2003; Rubenis 2007).
The physiotherapist is a member of the multidisciplinary team
(Robertson 2008; Rubenis 2007) and strives to maximise func-
tional ability and minimise secondary complications through
movement rehabilitation within a context of education and sup-
port for the whole person (Deane 2001a; Plant 2000). Physio-
therapy for PD focuses on transfers, posture, upper limb function,
balance (and falls), gait, physical capacity and (in)activity utilising
cueing strategies, cognitive movement strategies and exercise to
optimise the patient’s independence, safety and wellbeing, thereby
enhancing quality of life (Keus 2004; Keus 2007).
Referral rates to physiotherapy for peoplewith PDhave historically
been low (Mutch 1986; Yarrow 1999). However, in recent years
the number of referrals has increased, with a survey by Parkinson’s
UK in 2008 reporting that 54% of the 13,000 members surveyed
had seen a physiotherapist, compared with 27% in a survey under-
taken in 1998 (PDS 2008; Yarrow 1999). This rise in referralsmay
be attributed to two factors. Firstly, guidelines such as those pub-
lished by the National Institute for Health and Clinical Excellence
(NICE) (NICE CG35 2006) recommend that physiotherapy be
made available throughout all stages of the disease, raising the pro-
file of the intervention. This has been further supported by the
publication of Dutch physiotherapy guidelines (Keus 2004) (up-
dated guidelines were due for publication in 2013), which provide
specific information for physiotherapists involved in the manage-
ment of PD. Secondly, there has been a substantial increase in the
number of trials completed over the last decade (particularly in
the last five years), offering supportive evidence for the inclusion
of physiotherapy in the management of PD (Keus 2009).
A recent Cochrane review (Tomlinson 2012) assessed the effec-
tiveness of physiotherapy intervention versus no physiotherapy in-
tervention in patients with PD. The review provided evidence for
the short-term benefit (< three months) of physiotherapy inter-
vention in the treatment of PD. Further, it suggested that there
was no difference in treatment effect between the different types
of physiotherapy interventions being used, though this was based
on indirect comparisons. This now needs to be confirmed by ex-
amining head-to-head trials of physiotherapy interventions. This
would be of interest to both clinicians and patients so that appro-
priate physiotherapy interventions which provide greater benefit
can be delivered to PD patients (Tomlinson 2012).
The present Cochrane review was first published in 2001, and
included only seven randomised controlled trials with a total of
142 participants (Deane 2001b). The methods of physiotherapy
varied so widely across the trials that the data could not be com-
bined.This, alongwith the presence ofmethodological flaws, small
sample sizes, and the possibility of publication bias, led Deane et
al to conclude that there was insufficient evidence to support or
refute the efficacy of any given approach of physiotherapy over
another in PD (Deane 2001b). This review updates the previous
Cochrane review. It aims to compare the effectiveness of one ap-
proach of physiotherapy intervention versus another approach of
physiotherapy intervention in patients with PD.
O B J E C T I V E S
To assess the effectiveness of one physiotherapy intervention com-
pared with a second approach in patients with PD.
M E T H O D S
Criteria for considering studies for this review
Types of studies
All randomised controlled trials (including the first phase of cross-
over trials) comparing a physiotherapy intervention with another
physiotherapy intervention were considered for inclusion in the
review. Only trials that implemented random methods of treat-
ment allocation were included.
Types of participants
Participants with a diagnosis of PD (as defined by the authors of
the studies).
• PD of any disease stage (i.e. early or diagnostic,
maintenance, or complex phase).
• Any duration of PD.
• All ages.
• Any drug therapy.
• Any duration of physiotherapy treatment (although trials of
less than one day of treatment were excluded).
Types of interventions
Physiotherapy interventions aim to maximise functional ability
and minimise secondary complications through movement reha-
bilitation within a context of education and support for the whole
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person. Physiotherapy encompasses a wide range of techniques, so
we were inclusive in our definition of physiotherapy intervention
(including those not directly delivered by a physiotherapist) with
trials of general physiotherapy, exercise, treadmill training, cueing,
dance and martial arts being included.
Types of outcome measures
1. Gait outcomes such as:
a. two- or six-minute walk test (m), measures the number of me-
tres a person can walk in two or six minutes thereby providing a
measurement of walking endurance (Kersten 2004);
b. walking speed:
i. 10- or 20-metre walk test (s), measures the time in seconds
that a person takes to walk 10 or 20 metres thereby providing a
measurement of gait speed (Kersten 2004),
ii. velocity (m/s), measures the rate of change of position, recorded
in metres per second (Trew 2005);
c. cadence (steps/min), measures the number of steps taken in a
given period of time, which is then converted into the number of
steps taken per minute (Trew 2005);
d. stride length (m), measures the average distance (in metres)
between two successive placements of the same foot (Whittle
1996);
e. step length (m), measures the average distance (in metres) be-
tween successive foot to floor contact with the opposite feet (Trew
2005);
f. Freezing of Gait Questionnaire, a validated questionnaire for
the assessment of freezing of gait. The questionnaire consists of
six items and scores range from 0 to 24, with higher scores corre-
sponding to more severe freezing of gait (Giladi 2000).
2. Functional mobility and balance outcomes such as:
a. timed up and go (s), measures the time taken in seconds for
a person to get up from a chair, walk a certain distance (usually
threemetres), turn around and walk back to the chair and sit down
(Podsiadlo 1991);
b. Functional Reach Test (cm), “the maximal distance one can
reach forward beyond arm’s length, while maintaining a fixed base
of support in the standing position” (Duncan 1990);
c. Berg Balance Scale, a validated questionnaire designed to mea-
sure functional standing balance of the older adult. The measure
consists of 14 items and score ranges from 0 to 56; with 0 to 20 =
high fall risk; 21 to 40 = medium fall risk; and 41 to 56 = low fall
risk (Berg 1992; Qutubuddin 2005);
d. Activity SpecificBalanceConfidence. a 16-item self-report ques-
tionnaire that asks individuals to rate their confidence that they
will maintain their balance in the course of daily activities. Each
item is rated from 0% (no confidence) to 100% (complete confi-
dence) (Powell 1995; Talley 2008).
3. Data on falls such as:
a. number of patients falling, e.g. falls diary;
b. Falls Efficacy Scale, a 10-item patient-reported questionnaire
that measures how confident a person is at carrying out various
ADL. Items are rated from 1 to 10, with higher scores correlating
with lower levels of confidence, and a total score of 70 or more
indicating that a person has a fear of falling (Tinetti 1990);
c. Falls Efficacy Scale International, a 16-item questionnaire that
includes the 10 original items of the standard Falls Efficacy Scale as
well as six items regarding higher functioning and social activities.
Each item is rated on a scale of 1 to 4, with 1 being ‘not concerned
at all’ and 4 being ‘very concerned’ (maximum score out of 64)
(Yardley 2005).
4. Clinician-rated impairment and disability measures such as:
a. Hoehn and Yahr, a scale used to describe how symptoms of
Parkinson’s disease progress. Scale ranges from 0 to 5, with higher
levels indicating greater disability (Hoehn 1967);
b. Unified Parkinson’s Disease Rating Scale (UPDRS), designed
to assess motor impairment and disability in Parkinson’s disease.
Higher scores correspond to greater disability (Fahn 1987):
i. total, score ranges from 0 to 176,
ii. mental, score ranges from 0 to 16,
iii. ADL, score ranges from 0 to 52,
iv. motor, score ranges from 0 to 108;
c. Webster Rating Scale, an assessment of severity of disease and
clinical impairment against 10 items using a scale of 0 = normal to
3 = maximum impairment (bradykinesia, rigidity, posture, upper
extremity swing, gait, tremor at rest, facies, seborrhoea, speech, and
self care). Scores ranges from 0 to 30, with higher scores indicating
greater disease severity and disability (Webster 1968);
d. Columbia University Rating Scale, an assessment of motor im-
pairment and ADL against 13 items, using a five-point scale for
each to give a total score between 0 = normal to 65 = maximum
disability (Yahr 1969).
5. Patient-rated quality of life such as:
a. Parkinson’s Disease Questionnaire-39 (PDQ-39), a PD specific
health-related quality of life questionnaire containing 39 items
divided into eight domains. Scores range from0 to 100with higher
scores corresponding to poorer quality of life (Jenkinson 1997;
Peto 1995);
b. PDQUALIF, a PD specific health-related quality of life ques-
tionnaire containing 32 items in seven dimensions and one item
of global health-related quality of life. The total score ranges from
0 to 128 with higher scores indicating poorer quality of life (Welsh
2003);
c. PDQL, a PD specific health-related quality of life questionnaire
containing 37 items grouped into four subscales. Item scores range
from 1 to 5. The PDQL-Summary Index ranges from 37 to 185,
with higher scores reflecting better quality of life (Deboer 1996);
d. Short Form-36 (SF-36) or 12 (SF-12), a generic short form
health survey consisting of 36 or 12 questions. The SF-36 consists
of eight scaled scores assessing vitality, physical functioning, bodily
pain, general health perceptions, physical role functioning, emo-
tional role functioning, social role functioning and mental health.
Scores range from 0 to 100 with higher scores corresponding to
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better quality of life (Ware 1992).
6. Adverse events e.g. fractures, pain.
7. Compliance e.g. participant adherence, treatment fidelity.
8. Economic analysis.
Search methods for identification of studies
We undertook a systematic search of the literature up to the end
of January 2012 for publications or abstracts describing relevant
trials. This included searching the following.
1. General biomedical and science electronic databases (with-
out date limiters) including the Cochrane Movement Disorders
Specialised Register, The Cochrane Library, MEDLINE (1966 to
2012), EMBASE (1974 to 2012), CINAHL (1982 to 2012), ISI-
SCI (1981 to 2012); the rehabilitation databases AMED (1985
to 2012), REHABDATA (1995 to 2012), REHADAT (1990 to
2012), PEDro (1929 to 2012), GEROLIT (1979 to 2012); the
English language databases of foreign language research and third
world publications LILACS (1982 to 2012), MedCarib (17th
Century to 2012) and IMEMR (1984 to 2012).
2. The Cochrane Central Register of Controlled Trials (CEN-
TRAL), the CentreWatch Clinical Trials listing service, the
metaRegister of Controlled Trials, ClinicalTrials.gov, RePORT,
National Institute on Disability and Rehabilitation Research
(NIDRR) and National Research Register (NRR).
3. Handsearching of general (Lancet, BMJ, JAMA) and spe-
cific journals (Movement Disorders,Neurology,Archives of Physical
Medicine and Rehabilitation,Clinical Rehabilitation,Physiotherapy,
Physical Therapy) from 2001 to the end of January 2012.
4. The reference lists of retrieved papers and review articles.
5. Abstract books and conference proceedings. This included The
XIII International Congress on Parkinson’s disease (1999), The
International Congress of Parkinson’s Disease andMovement Dis-
orders (1990, 1992, 1994, 1996, 1998, 2000, 2002, 2004, 2005,
2006, 2007, 2008, 2009, 2010, 2011, 2012), World Congress on
Parkinson’s Disease and Related Disorders (2009) and The Amer-
ican Academy of Neurology 51st annual meeting (1999).
6. Grey literature databases (including theses): Conference Pro-
ceedings Citation Index (1982 to 2012), DISSABS (1999 to
2012), Conference Papers Index (1982 to 2012), Index to Theses
(1970 to 2012), Electronic Theses Online Service (EThOS) (16th
Century to 2012) and ProQuest dissertations and theses databases
(1861 to 2012).
The search strategies are listed in full in Appendix 1.
Data collection and analysis
Selection of studies
From the search results, two review authors (CLT, CPH, SP or LS)
independently screened the abstracts of potentially relevant stud-
ies, with the full paper being obtained if the abstract did not pro-
vide sufficient information to determine eligibility for inclusion in
the review. Disagreement was resolved by referral to a third review
author (RS, CM or NI). Authors of potentially eligible studies
were contacted for further information if details of their trial were
unclear.
Data extraction and management
Two review authors (CLT, CPH, SP or CM) independently as-
sessed the eligible papers or abstracts for trial details and outcome
data. These were validated by discussion with any discrepancies re-
solved by consensus. Trial details were recorded on a standard trial
description form and included: trial name, trial group, authors,
randomised comparison, treatment schedule (including duration,
number of sessions, type of intervention), other therapy, eligibility
criteria, method of randomisation, allocation concealment, blind-
ing, accrual period, number of participants randomised, number
of dropouts, duration of follow-up, outcomes reported, use of
intention-to-treat analysis and publication date(s). The outcome
data extracted included data on gait, functional mobility and bal-
ance, falls, clinician-rated disability scale and patient-rated qual-
ity of life, adverse events, compliance or withdrawals and health
economics where available.
Authors of any eligible unpublished studies were contacted to ask
if further details and the data for their trial could be provided.
Assessment of risk of bias in included studies
Two review authors (CLT, CPH, SP or CM) assessed the method-
ological quality of the full papers by recording the eligibility cri-
teria (for example specified inclusion (and exclusion) criteria -
low risk), method of randomisation (for example used computer
random number generator - low risk) and blinding (for example
blinding of assessors - low risk), concealment of allocation (for
example use of central randomisation service - low risk), similar-
ity of participants in treatment groups at baseline (no difference
in baseline characteristics between treatment groups as stated in
trial publication - low risk), co-intervention(s) constant (for ex-
ample drug therapy stable - low risk), comparable treatment arms
(for example similar treatment duration and frequency - low risk),
whether an intention-to-treat analysis was performed (intention-
to-treat analysis and withdrawals < 10% - low risk, withdrawals
> 10% - unclear risk, per protocol analysis - all unclear risk) and
the number of participants lost to follow-up and missing values
(withdrawals below 10% - low risk) (see the risk of bias tables
under ’Characteristics of included studies’).
Data synthesis
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Treatment arms of the included studies were classified and divided







Disparate study designs in the included trials resulted in a lack
of overlap in the collated physiotherapy methods and outcome
measures such that data could not be combined in a meaningful
way.
R E S U L T S
Description of studies
A total of 78 randomised trials of physiotherapy intervention
in PD patients were identified; 29 studies were excluded (see
Characteristics of excluded studies). The reasons for excluding
these trials were: not randomised or not properly randomised (n
= 12), cross-over study with data for the different phases not ade-
quately separated (n = 4), treatment given in trial not usually used
by physiotherapists (such as whole body vibration technique) (n =
4), no outcome measures relevant to our review (n = 2), multidis-
ciplinary therapy rehabilitation trial (n = 2), trial duration under
one day (n = 1), insufficient information available for inclusion
in review (n = 1), unsuitable comparator arm (n = 1), study was
confounded (n = 1) and comparison of physiotherapy delivery
rather than technique (n = 1). There were also six ongoing trials for
which data were not yet available (see Characteristics of ongoing
studies). Therefore, there were 43 trials available for inclusion in
the review, compared to seven in the 2001 review (Figure 1).
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Figure 1. PRISMA flow diagram.
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The number of participants randomised into each of the 43 tri-
als ranged from eight to 210 participants, with 1673 participants
randomised in total (giving an average trial size of 39 participants)
(see Characteristics of included studies). The assessment period
ranged from two weeks to 24 months. The mean age of the partic-
ipants in the trials was 67 years, 62% were male, the mean Hoehn
and Yahr stage was 2.4, and they had had PD for approximately
seven years.
There were 14 three-arm trials. Eight trials compared two differ-
ent experimental physiotherapy interventions with placebo or no
intervention (Almeida 2012; Fisher 2008; Li 2012; Mak 2008;
McGinley 2012; Shankar 2009;Talakkad 2011;Thaut 1996). The
placebo or no intervention arms of these trials were not included in
any analysis for this review (see Tomlinson 2012). Six trials com-
pared three different physiotherapy techniques (Chaiwanichsiri
2011; Ebersbach 2010; Juncos 2006; Reuter 2011; Schenkman
2012a; Toole 2005). There was also one four-arm trial comparing
two types of dance (waltz or foxtrot and tango) and martial arts
with no intervention (Hackney 2009).
Risk of bias in included studies
See the Characteristics of included studies risk of bias in included
studies tables, risk of bias graph (Figure 2) and risk of bias summary
(Figure 3).
Figure 2. Risk of bias graph: review authors’ judgements about each risk of bias item presented as
percentages across all included studies.
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Figure 3. Risk of bias summary: review authors’ judgements about each risk of bias item for each included
study.
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Trial design
A total of 40 trials had a parallel design and three had a cross-over
design (Burini 2006;Miyai 2000; Shiba 1999). Most trials looked
at the short-term effect of therapy by assessing the participants at
baseline and immediately or shortly after the physiotherapy inter-
vention period (which ranged from two weeks to 24 months). Of
the parallel design trials 21 reported additional data at assessment
points after the treatment period had finished; this may have been
at only two weeks or up to 12 months after the end of the treat-
ment period.
Sample size
Only 13 studies (30%) (Braun 2011; Hackney 2007; Hackney
2009; Hackney 2010; Hirsch 1996; Li 2012; McGinley 2012;
Morris 2009; Picelli 2012; Reuter 2011; Schenkman 2012a;
Smania 2010; Yang 2010) reported a sample size calculation in
the trial report, which was achieved by seven studies.
Eligibility criteria
The eligibility criteria for the trials were broad and varied consider-
ably across the trials. The level of detail provided on the eligibility
criteria was also variable, with some studies providing a detailed
description of the entry criteria and others just stating ’patients
with Parkinson’s disease’. Only four trials (Pelosin 2010; Reuter
2011; Schenkman 2012a; Yang 2010) stated that a diagnosis of
PD by the United Kingdom Brain Bank Criteria (Gibb 1988) was
required. It is vital that eligibility criteria are well-defined so that
the trial participant population can be determined.
Randomisation method and concealment of allocation
A total of 24 trials (56%) described the randomisation method
used, of which only eight trials used low risk methods (for ex-
ample computer random number generators). No details of the
randomisation method used were provided for the remaining 19
trials. Further, only 20 trials (47%) either stated or gave adequate
information that allowed the assessment of whether an adequate
concealment of treatment allocation procedure had been used.
Four trials were considered to be low risk by virtue of having used
a central independent randomisation service, with the other 16
considered high risk (that is concealment of treatment allocation
was potentially compromised as sealed envelopes, picking a card
or picking from a hat were used).
Blinding of assessors
It would be impossible to blind participants and therapists to ran-
domised treatment allocation in trials of physiotherapy.Therefore,
such trials are open label by nature, and they are consequently liable
to the possibility of both performance and attrition bias. However,
blinding of assessors could be employed to try and reduce the pos-
sibility of bias; 23 (53%) of the 43 studies used blinded assessors,
seven used unblinded assessors so were classed as high risk, and in
the other 13 studies this information was not provided (classed as
unclear risk).
Co-interventions
Information on co-interventions was provided in 24 trials (56%),
with participants continuing with their standard PD medication.
In 20 trials the drug therapy was kept stable (low risk) through-
out the duration of the trial, whereas five trials allowed variation
(unclear risk). The remaining trials did not describe drug therapy
(unclear risk).
Similarity of treatment groups at baseline
A description of the baseline characteristics of the trial participants
is important to determine whether the trial results are general-
isable and to compare characteristics of the two arms to ensure
that the randomisation methods were successful. Six trials (Diehl
2011; Joudoux 2011; Khallaf 2011; Shankar 2009; Shen 2011;
Talakkad 2011) did not provide any information on the baseline
characteristics of the participants entered into the trial; 31 (of the
37) trials that reported baseline data gave this information split
by treatment group; 25 trials reported sufficient data that showed
participants to be similar at baseline. In six trials the baseline char-
acteristics of the withdrawn participants were not given (Hackney
2009; Mak 2008; Miyai 2002; Picelli 2012; Smania 2010; Yang
2010). Along with the six trials that did not supply baseline data,
this meant that 274 (16%) of the 1693 randomised participants
were not characterised.
Data analysis
Ten trials stated intention to treat as the primary method of anal-
ysis, although it was not always clear if participants who with-
drew from the trial were included in the analysis. The number of
participant withdrawals was classed as low risk (≤ 10% of trial
participants withdrew) in five of the 10 trials. Four trials used per
protocol as the method of analysis (unclear risk). In the other 29
trials the method of analysis was not described (unclear risk), of
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these trials seven were considered high risk in terms of the propor-
tion of participants that withdrew (that is > 10%), and in 13 trials
the number of participant withdrawals (if any) was not described
(unclear risk).
Available trial information and data
A total of 13 trials were reported in abstract form; further infor-
mation was requested from the authors (two were not contactable:
Khallaf 2011; Shiba 1999)with four (Juncos 2006; Poliakoff 2009;
Robichaud 2012; Shankar 2009) providing additional informa-
tion and seven (Diehl 2011; Hass 2006; Joudoux 2011; Loureiro
2010; Shen 2011; Sigurgeirsson 2009; Talakkad 2011) being un-
successful. A total of 30 trials were reported as full publications;
further information was requested from authors for 26 trials with
13 providing additional information.
Effects of interventions
See ’Summary of results’ table for included trials (Table 1).
The physiotherapy interventions were placed into one of the six
categories (general physiotherapy, exercise, treadmill training, cue-
ing, dance and martial arts) according to the type of treatment
administered. However, the content and delivery of the interven-
tions within each category were diverse and varied substantially.
Further, a wide variety of validated and customised outcome mea-
sures were used to assess the effectiveness of the physiotherapy
interventions. Consequently, it was inappropriate to combine the
results of studies or perform any statistical analysis.
Nevertheless, results of the most regularly used outcome measures
could be examined on a trial by trial basis. The most frequently
reported physiotherapy outcome measures were gait speed and
timed up and go. The motor subscales of the UPDRS and PDQ-
39 were the most commonly reported clinician-rated disability
and patient-rated quality of life outcome measures respectively.
Falls data were also considered to be an important outcome in PD.
Even in the case of these more widely reported outcome measures,
quantitative meta-analysis could not be performed due to the wide
variety of interventions employed by the included studies such
that no two studies with comparable interventions assessed the
same outcome measure.
Gait speed (m/s)
Gait speed was measured in 19 studies with data available from
15 studies; data were inadequately or not reported for four tri-
als (Juncos 2006; Khallaf 2011; McGinley 2012; Shen 2011).
Nine (Almeida 2012; Chaiwanichsiri 2011; Fisher 2008; Hackney
2007;Hass 2006; Li 2012;Miyai 2000; Vivas 2011;Werner 2010)
of the 15 studies reported no difference between the two interven-
tion arms. In five studies (Dias 2005 (mean difference between
arms 0.34 m/s); Frazzitta 2009 (mean difference between arms
0.1 m/s); Miyai 2002 (mean difference between arms 0.16 m/
s); Thaut 1996 (mean difference between arms 0.093 m/s); Yang
2010 (mean difference between arms 0.15m/s)) the gait speed was
significantly increased in the novel experimental arm compared to
the comparator arm. The remaining study (Hackney 2009) was a
three-arm trial. Hackney (Hackney 2009) recorded significantly
greater gait speed in the tango arm compared to the waltz/foxtrot
arm (mean difference between arms 0.06m/s), but not the Tai Chi
arm.
Timed up and go (s)
The timedup and go testwas reported in 15 studies with data avail-
able from 14 studies; data were inadequately or not reported for
one study (McGinley 2012). There was no difference between the
two intervention arms for 12 studies (Almeida 2012; Braun 2011;
Chaiwanichsiri 2011; Hackney 2007; Hackney 2010; Li 2012;
Loureiro 2010; Morris 2009; Pelosin 2010; Robichaud 2012;
Sigurgeirsson 2009; Vivas 2011). In the Ebersbach (Ebersbach
2010) study, the time taken to complete the timed up and go test
was significantly improved (that is reduced) with the Lee Silver-
man voice treatment (LSVT) BIG arm compared to the Nordic
walking and home exercise arms. In the Hackney (Hackney 2009)
study, the timed up and go test was significantly improved in the
tango arm compared to the waltz or foxtrot and Tai Chi arms.
Falls
Outcome measures that report data on falls are important and
pertinent in PD studies. However, only five trials reported data on
falls (11%) (Hirsch 1996; Juncos 2006; Li 2012; McGinley 2012;
Smania 2010).
Hirsch 1996 reported the effect of training on mean latency to
fall (average number of seconds participants swayed before step-
ping or falling, touching the surrounding panels with hands, or
needing assistance from the technician to keep from sitting in the
harness) and the proportion of falls (number of trials resulting in
falls). There were no significant differences between the combined
balance and resistance arm and balance only arm for either out-
come.
Juncos 2006was published in abstract form. There was insufficient
information on the falls data collected to allow a description of
the manner in which falls were analysed or to give any indication
of the result.
Li 2012monitored falls using daily ‘falls calendars’ that weremain-
tained by study participants. There were no differences between
the Tai Chi and resistance training arms.
McGinley 2012 measured the number of fallers, the number of
multiple fallers and falls rate. The number of falls during the in-
tervention phase (eight weeks) was significantly lower in the pro-
gressive strength training arm compared to the movement strategy
training arm (n = 10 versus n = 24; P = 0.006), with the frequency
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of falls varying markedly. However, the time to first fall did not
differ significantly between groups (P = 0.4).
Smania 2010 reported the number of falls by means of a falls
diary. A diary of the number of falls, their circumstances, and the
consequences for the patient’s health were kept for one month
prior to each evaluation session.Therewas no significant difference




Themotor subscale of the UPDRS was reported in 23 studies with
data and information available from 17; data were inadequately or
not reported for six studies (Joudoux 2011; Khallaf 2011; Reuter
2011; Shankar 2009; Shen 2011; Toole 2005). There was no dif-
ference between the two intervention arms for 14 studies (Almeida
2012; Burini 2006; Fisher 2008; Frazzitta 2009; Hackney 2007;
Hackney 2009; Juncos 2006; Li 2012; McGinley 2012; Miyai
2000; Miyai 2002; Poliakoff 2009; Robichaud 2012; Schenkman
2012a). In the Ebersbach 2010 study, the UPDRS motor score
was significantly improved in the LSVT BIG arm compared to
the Nordic walking and home exercise arms. In the Ridgel 2009
study, UPDRS motor scores showed a significantly greater im-
provement in the forced exercise arm compared to the voluntary
exercise arm. In the Talakkad 2011 study, partial weight supported
(-20%) treadmill training had a significantly greater improvement
in UPDRS motor score compared to conventional gait training
(no data in publication).
Patient-rated quality of life
PDQ-39 (Summary Index)
A total of 13 studies described using data from the PDQ-39 but
the data were only available from eight studies; data were inade-
quately or not reported in five studies (Joudoux 2011; McGinley
2012; Reuter 2011; Shankar 2009; Sigurgeirsson 2009). Seven
studies (Burini 2006; Ebersbach 2010; Juncos 2006;Morris 2009;
Pelosin 2010; Poliakoff 2009; Schenkman 2012a) reported no dif-
ference between the intervention arms. Only the Hackney 2009
trial reported a significant difference, with quality of life scores
significantly improved in the tango arm compared to the waltz or
foxtrot and Tai Chi arms.
Adverse events
Nine trials recorded adverse event data (Chaiwanichsiri 2011;
Fisher 2008; Li 2012; McGinley 2012; Picelli 2012; Poliakoff
2009; Reuter 2011; Schenkman 2012a; Yang 2010). Minor ad-
verse events such as muscle soreness, falls and dizziness were
reported, with none of these trials reporting events significant
enough to cause concern over the safety of the intervention.
Compliance
Only 18 of the 43 trials discussed participant compliance, with 13
(Burini 2006; Ebersbach 2010; Hackney 2007; Hackney 2009;
Hirsch 1996; Li 2012; McGinley 2012; Miyai 2000; Miyai 2002;
Poliakoff 2009; Reuter 2011; Thaut 1996; Toole 2005) quantify-
ing it in some form; however this was difficult to analyse.
Health economics
Only one trial (McGinley 2012) intended to look at health eco-
nomics.Watts 2008 (SeeMcGinley 2012) published a protocol for
economic analysis alongside the McGinley trial. They proposed
to evaluate cost-effectiveness using a three-way comparison of the
cost per fall averted and the cost per quality adjusted life year saved
across two physical therapy interventions and a control group.
D I S C U S S I O N
Summary of main results
This review updates the previous Cochrane review published in
2001 (Deane 2001b) comparing the effectiveness of one approach
of physiotherapy intervention versus a second approach of physio-
therapy intervention for the treatment of PD. The review now in-
cludes 43 randomised trials and 1693 participants (compared with
seven trials and 142 participants in the 2001 review). Many recent
systematic reviews have focused on specific areas of physiotherapy
such as exercise, cueing and treadmill training (Allen 2011; Crizzle
2006; Goodwin 2008; Lim 2005; Mehrholz 2010; Nieuwboer
2008). Physiotherapy for PD encompasses a wide range of meth-
ods and techniques ranging from standard UK National Health
Service (NHS) physiotherapy to exercise regimens and martial arts
(Tomlinson 2012). Therefore, it is important that all approaches
of physiotherapy intervention are included. Physiotherapy inter-
ventions were placed into six categories according to the type of
treatment administered. However, the content and delivery of the
interventions within each category varied substantially. In view of
the disparate study designs, variety of interventions, and the array
of outcome measures used the results of individual studies could
not be combined using quantitative meta-analysis methods.
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Comparison of different physiotherapy interventions
A recent Cochrane review provided evidence on the short-term
benefit of physiotherapy in the treatment of PD (Tomlinson
2012). However, it did not identify whether any specific type of
physiotherapy intervention provides greater benefit. This review
aimed to assess this by comparing the effectiveness of one approach
of physiotherapy intervention with a second approach of phys-
iotherapy intervention. The various physiotherapy interventions
used in the trials included in this reviewwere categorised according
to the type of treatment administered to aid comparisons (general
physiotherapy, exercise, treadmill training, cueing, dance, martial
arts). However, despite categorisation, the techniques employed
within each category were diverse. Therefore, it was not possible
or appropriate to combine the results by meta-analysis as any such
analysis would be difficult to interpret. It is also difficult to sum-
marise such large amounts of heterogeneous data using a qualita-
tive approach. Consequently, we conclude that there is no robust
trial evidence to support any one approach of physiotherapy over
another in the treatment of PD.
The content and delivery of the interventions used in the trials
included within this review were diverse in nature. Although at-
tempts weremade to compare trials that were ’like for like’ through
the creation of different categories, the interventions delivered var-
ied substantially within these categories. In the future it may be
useful to further subcategorise by the primary aim of the trial.
For example, categories for the primary aim might be to improve
gait or improve a specific problem such as gait freezing or balance,
or improve overall PD performance or function. The variation
in the therapy delivered is unsurprising. Physiotherapy is an au-
tonomous profession. Physiotherapists use different sets of skills
and work within their own scope of practice (Chartered Society of
Physiotherapy), and so this variation in the interventions delivered
within clinical trials may reflect the diversity of clinical practice.
Over the past decade, steps have been taken to try and provide
best practice consensus in the form of the Dutch KNGF guidelines
for physical therapy in patients with Parkinson’s disease (Keus 2004).
However, this publication provides a guidance framework rather
than a ’recipe’ for treatment. It is therefore important that physio-
therapy interventions are compared against each other within rig-
orous trial designs to determine which are the most effective. This
will provide therapists with a menu of treatment strategies that are
known to be effective, from which they can devise individualised
interventions. However, given the complexity of physiotherapy in-
terventions, it is important that such trials follow the Medical Re-
search Council guidelines for developing and evaluating complex
interventions (MRC 2008), which will help standardise interven-
tions. In addition, many of the trials included in this review had
interventions that were intensive and for long durations, which
may not be feasible in main stream care. Therefore, future trials
should be designed such that the interventions are transferable and
cost-effective in main stream care.
Outcome measures
There was a large variety of outcomemeasures utilised in the differ-
ent studies included in this review. The majority of the outcomes
were standard physiotherapy and PD outcomes. Gait speed, timed
up and go, UPDRS motor score and quality of life measured us-
ing the PDQ-39 were themost frequently reported outcome mea-
sures within their respective categories. PD is a multidimensional
disease and several important outcomes were either poorly or not
reported; this includes data on the number of the falls, depression
and anxiety and adverse events. Further, many of the outcomes
measured were not relevant to the PD patient or carer. There is
a need for the use of functional gait outcomes in future trials
which look at the impact on the patient during everyday living
rather than in a laboratory environment. Further, only one trial
intended to look at a health economics analysis of physiotherapy
intervention, therefore little is known about the cost-effectiveness
and economic value of this therapy. Future trials should include
these outcomes.
Gait speed
Six trials (Dias 2005; Frazzitta 2009; Hackney 2009; Miyai 2002;
Thaut 1996; Yang 2010) reported significant differences between
the treatment arms for gait speed. The observed differences be-
tween treatment arms ranged from 0.06 to 0.34 m/s. In all these
trials, with the exception of Hackney 2009, the intervention arm
that used cueing or treadmill training methods, or both, was the
better treatment arm. The Hackney trial (Hackney 2009) exam-
ined dance with the tango arm outperforming the waltz or foxtrot
arm. The possible relevance and benefit of these significant differ-
ences to patientswith PDmust be put into context in terms ofwhat
is considered a minimally clinically important change (MCIC).
Data on what is considered an MCIC are lacking for PD patients,
but some data have been reported in stroke patients. In one study,
it was reported that an increase in speed of just 0.03 and 0.13 m/
s could translate into a change from a limited household to an
unlimited household walker, and from an unlimited household
walker to a most-limited community walker, respectively (Perry
1995). Therefore, these differences in gait speed between arms are
consistent with the findings reported by Perry (Perry 1995).
Timed up and go
The MCIC in PD patients is thought to be 11 seconds (Steffen
2008). The differences seen between treatment arms in the Ebers-
bach (Ebersbach 2010) and Hackney trials (Hackney 2009) were
much smaller than this (the mean difference between arms ranged
from 1.1 to 2 seconds).
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UPDRS motor subscale
Three trials reported a significant benefit of one treatment arm
in improving UPDRS motor over the other arms. The UPDRS
motor score in the LSVT BIG arm in the Ebersbach (Ebersbach
2010) trial improved by 5.05 points, which was significantly dif-
ferent from the two other arms in which the score increased (that
is got worse) by 0.53 and 1.68 points in the Nordic walking and
home exercise arms, respectively. Ridgel (Ridgel 2009) reported a
significant difference in UPDRS motor score between the forced
exercise arm (-16.6 points) and the voluntary exercise arm (3.6
points). Additionally, Talakkad (Talakkad 2011) reported a sig-
nificantly greater improvement of the UPDRS motor score in the
partial weight supported (-20%) treadmill training compared to
conventional gait training, although there were no data in the ab-
stract publication. The MCIC for the UPDRS motor score has
been reported in two studies. One analysed data from two in-
dependent randomised controlled trials and concluded that the
MCIC was five points for the motor score (Schrag 2006). The
second study performed a cross-sectional analysis on 653 PD par-
ticipants and reported a MCIC of 2.3 to 2.7 points for the mo-
tor score (Shulman 2010). Considering the recommendations of
both Schrag (Schrag 2006) and Shulman et al (Shulman 2010)
the improvements seen in the Ebersbach (Ebersbach 2010) and
Ridgel (Ridgel 2009) trials may reflect a MCIC.
Patient-rated quality of life
A study performed by Peto et al (Peto 2001) to determine the
MCIC for the PDQ-39 Parkinson’s questionnaire reported that a
difference of 1.6 on the summary index was a meaningful change.
Only the Hackney 2009 trial reported a significant difference,
with quality of life scores significantly improved by 7.10 points
in the tango arm, which was significantly different from the waltz
or foxtrot arm that improved by 0.68 points and the Tai Chi arm
which had an increased score of 1.55 points (that is got worse).
This improvement in quality of life that was seen in the tango arm
is therefore meaningful to patients.
Quality of the evidence
There has been an improvement in the trial methodological qual-
ity and reporting since the last Cochrane review (Deane 2001b).
The use of more robust randomisation methods, blinding and in-
tention-to-treat analyses has increased since the previous review,
although it was still inadequate. Of the 43 trials, only 24 trials
provided information on the randomisation method (of which
eight were considered low risk) and only four used a central inde-
pendent randomisation procedure to ensure concealment of treat-
ment allocation; 23 trials used blinded assessors and only 10 stated
that they used intention-to-treat analysis methods. The lack of in-
formation in many trial reports may not necessarily indicate lack
of implementation within the trial, but without this information
provided in the trial publications the level of bias within the indi-
vidual trials is difficult to assess. The need for further improvement
in the methodological quality of trials in physiotherapy for PD
was noted recently (Kwakkel 2007; Tomlinson 2012). Future tri-
als must be methodologically sound, large, randomised, and con-
trolled with reporting following CONSORT guidelines (Boutron
2008a; Boutron 2008b).
The trials included in the review were relatively small, with the
majority assessing the effect of one approach of physiotherapy in-
tervention versus a second approach of physiotherapy intervention
over a short period of time, with limited follow-up. The overall
size of trials has increased (with an average of 39 participants per
trial in this review compared to 20 in the previous review), but
the number of small and underpowered trials remains a problem.
Small trials may be subject to ‘random error’ (Doll 1980) and con-
sequently may give rise to false negative or positive results. Fur-
ther, it must be noted that the mean age of onset of PD in the
participants in the trials was 60 years. This is relatively young as
the average age of onset in the PD MED trial is 67 to 69 years
(Patel 2010), therefore the results of the trials may not be relevant
to the general PD population, in particular older PD patients.
It should also be noted that only 18 of the 43 trials discussed par-
ticipant compliance. This is surprising as compliance can be an
important determinant of the outcomes measured and the accept-
ability of the interventions being assessed in the trials. Therefore,
it would be beneficial if the level of compliance is measured in
future trials.
Another limitation is that the follow-up period in the trials in-
cluded in this review was relatively short. Outcomemeasures were
assessed in all trials at baseline and immediately or shortly after
the intervention had ceased (one or two weeks, with one trial
(Ebersbach 2010) assessing at 12 weeks post-intervention). PD is
a long-term neurodegenerative disease, so it is important that the
long-term effect of treatment is assessed. Only half of the 43 tri-
als followed-up participants and reported further data during the
post-treatment period (but this could have been only two weeks
or up to 12 months post-treatment). The previous review’s recom-
mendations were for participants to be followed-up for at least six
months. Only two trials did this, reporting follow-up data at 12
months (McGinley 2012) and at both 6 and 12 months (Werner
2010) post-treatment. Long-term data will provide valuable infor-
mation about the duration of any improvement following therapy.
Reporting biases
Many trials used multiple outcome measures, and in the majority
of trials the primary outcome measure was not explicitly stated.
Therefore, it was difficult to assess and identify if studies were free
of selective outcome reporting.
In order to minimise the risk of publication bias, a comprehensive
search was performed of multiple databases, including searching
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of unpublished and ongoing studies, without any language restric-
tions. Also, where necessary, authors were contacted to request
additional information. However, as with any systematic review,
publication bias should still be taken into consideration.
In summary, large, well-designed randomised trials with improved
specific treatment strategies and a follow-up of at least 12 months
that assess the impact of treatment on all aspects of a patient’s PD,
alongside a health economics assessment, are needed.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
Considering the small number of participants, themethodological
flaws in many of the studies, the wide variety of physiotherapy
interventions and outcome measures used, there is insufficient
evidence to support the use of one approach of physiotherapy
intervention over another for the treatment of PD.
Implications for research
• The majority of the studies included in this review were
small and had a short follow-up period. It is clear that larger
randomised controlled trials with longer-term follow-up are
required, particularly focusing on improving trial methodology
and reporting. Rigorous methods of randomisation should be
used and the allocation should be adequately concealed. Data
should be analysed according to intention-to-treat principles and
trials should be reported according to the guidelines set out in
the CONSORT statement (Boutron 2008a; Boutron 2008b).
• This review highlights the variety of physiotherapy
interventions being tested for the treatment of PD. There is a
need for more specific trials with improved treatment strategies
to underpin the most appropriate choice of physiotherapy
intervention and the outcomes measured. This review also
reinforces the need for the universal employment of clinically
relevant, reliable and sensitive outcome measures with a
predefined outcome in each trial.
• Future trials should, where appropriate, try to follow the
Medical Research Council guidelines for developing and
evaluating complex interventions (MRC 2008).
• Future trials should be designed such that the interventions
are transferable and cost-effective in main stream care.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Almeida 2012
Methods Parallel group design
Randomised by pulling allocation out of a hat
Analysed on a per protocol basis
Treated as outpatients for 9 hours over 6 weeks
Assessed at baseline, 6 weeks and 12 weeks
Assessors were blinded for UPDRS III evaluation
Participants 14 participants in the Overground walking group (OG), 14 in the Treadmill walking group (TM) and
14 in the control group (CL). 2 dropouts in TM group, 1 dropout in CL group
Participants’ mean age 73.9 years (OG), 63.9 years (TM), 67.4 years (CL); male/female 12/2 (OG), 8/
6 (TM), 11/3 (CL); Hoehn and Yahr stage not stated; duration of PD not stated
Inclusion criteria: Confirmed as having clinically typical Parkinson’s disease by at least one movement
disorders neurologist. Exclusion criteria: Past history of neurological conditions other than Parkinson’s
disease, orthopaedic or visual disturbances that severely impaired walking ability, unable to indepen-
dently walk down an 8 metre GAITRite carpet for a total of 10 trials
Interventions OG: Walk down equally spaced transverse lines presented on a 16m carpet. The cues were white lines
of tape. Participants asked to walk across the lines, turn and continue back. Spacings were set at 8%
greater than the initial step length of any of the groups (70 cm). 30 minute session with mandatory 2
min break every 8 mins, additional rest allowed if necessary but a total of 24 mins walking was required
to consider gait session complete
TM:Walk on a treadmill presentedwith equally distributed standardised transverse white lines. Spacings
were set at 8% greater than the initial step length of any of the groups (70 cm). 30 minute session with
mandatory 2 min break every 8 mins, additional rest allowed if necessary but a total of 24 mins walking
was required to consider gait session complete
CL: Instructed to continue their usual activities.
Participants were optimally medicated at time of all training and testing sessions and remained on stable
regimen throughout trial period
Outcomes Step length
UPDRS III





Step-to-step variability, step time variability
30 second chair stand
Notes CL arm not included in review
Risk of bias
Bias Authors’ judgement Support for judgement
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Almeida 2012 (Continued)
Eligibility Criteria Low risk Inclusion and exclusion criteria stated
Randomisation Method High risk Allocation pulled out of hat
Concealment of Allocation High risk Allocation pulled out of hat
Similarity at Baseline Low risk Group characteristics similar at baseline
Intention to Treat Analysis Unclear risk Analysed on a per protocol basis
Withdrawals Described Low risk Withdrawals at less than 10%
Cointerventions Constant Low risk Participants maintained stable drug regiment
throughout trial period
Comparable arms Low risk Same time and attention given to both arms
Blinded Assessors Unclear risk Assessors blind for UPDRS III evaluation only
Braun 2011
Methods Parallel group design
Random allocation list used for each site with block sizes of 4
Both intention-to-treat and per protocol analysis were carried out
Treated as outpatients for either 1 hour per week (groups) or 30 mins per week (individuals) over 6
weeks
Assessed at baseline (week 0-1), at 7-8 weeks and at 3 months (12-13 weeks)
Assessors were blinded
Participants 25 participants in the physiotherapy with mental practice group (PT+MP) and 22 in the physiotherapy
and relaxation group (PT+R). There were 3 dropouts PT+MP group and 4 in the PT+R group prior
to the post-intervention assessment, and a further 4 dropouts in the PT-MP group and 3 in the PT-R
group prior to the 3 month follow-up assessment
Participants’ mean age 70 years (PT-MP), 69 years (PT-R); Male/female ratio, 17/8 (PT-MP), 15/7
(PT-R); Mean Hoehn and Yahr not given; Mean duration of PD 5.2 years (PT-MP), 6.6 years (PT-R)
Inclusion criteria: Clinically diagnosed adults with PD, sufficient cognitive level and communication
skills to engage mental practice. Exclusion criteria: Other conditions such as stroke, rheumatic disease
or dementia prior to onset of PD and sufficient to cause persistent premorbid disability
Interventions Participants entering the trial were already receiving physiotherapy. This pre-existing treatment was
continued. The randomly allocated new treatment was incorporated into the participants existing
program
PT-MP: In half hour sessions 10 mins were spent on mental practice, in group sessions of 1 hour,
20 mins were spent on mental practice. Therapy was recorded in pre-structured files which detailed
content and duration. As soon as possible therapists encouraged unguided mental practice. Logs were
given to participants to record unguided mental practice behaviour. The main goal of mental practice
was to improve locomotor tasks like walking, standing up from a chair or the floor. This was achieved
through four steps, explaining the concept, developing imagery techniques, applying mental practice
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Braun 2011 (Continued)
and consolidating. During therapy imagery attempts and overt movements were combined. This in-
formation was embedded in the imagery attempts to make them as vivid as possible. The proportions
of actual movements and imagery attempts were based on individual preferences
PT-R: In half hour sessions 10 mins were spent on relaxation, in group sessions of 1 hour, 20 mins
were spent on relaxation. Therapy was recorded in pre-structured files. As soon as possible therapists
encouraged unguided relaxation. Logs were given to participants to record unguided practice. Used to
control for attention and consisted of treatment according to the national Dutch guidelines with relax-
ation therapy being incorporated into each session. The amount of relaxation incorporated matched the
amount of mental practice in the experimental group. Relaxation followed the principles of progressive
muscle relaxation
It was not stated whether drug therapy was kept constant during the trial
Outcomes Patient and therapist perceived effect on walking performance using visual analogue scale
Timed up and go
10 m walk test
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Eligibility Criteria Low risk Inclusion and exclusion criteria
Randomisation Method Unclear risk Random allocation list not clear how generated
Concealment of Allocation Low risk Lists kept by independent 3rd party
Similarity at Baseline Unclear risk Hoehn and Yahr not stated
Intention to Treat Analysis Unclear risk Primary analysis was ITT then per protocol was
carried out
Withdrawals Described High risk Withdrawals > 15% prior to post-intervention as-
sessment
Cointerventions Constant Unclear risk Not statedwhether drug therapywas kept constant
during the trial
Comparable arms Low risk Same time and attention given in both arms
Blinded Assessors Low risk Assessors were blinded
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Burini 2006
Methods Cross-over design
Participants coupled consecutively with list of random numbers. Numbers correspond to a sealed
envelope containing group allocation
Method of analysis not stated
Treatment delivered to groups in 45-50 minute sessions, 3 times per week up to a total of 20 sessions
Assessed at Baseline, after 7 weeks of first treatment, after 8 weeks wash-out period, after 7 weeks of
second treatment
Assessors were blinded
Participants 13 participants in the aerobic training group and 13 in the Qi-gong group. There were 2 dropouts in
each group
Participants’ mean age 65.7 years (aerobic training), 62.7 years (Qi-gong); Male/female ratio, 5/8
(aerobic training), 4/9 (Qi-gong); Mean Hoehn and Yahr 2.8 (aerobic training), 2.7 (Qi-gong); Mean
duration of PD 11.2 years (aerobic training), 10.6 years (Qi-gong)
Inclusion criteria: PD subjects, stable medication, Hoehn and Yahr stage II to III. Exclusion criteria:
Severe cognitive impairment (MMSE < 24), concomitant severe neurologic cardiopulmonary or or-
thopaedic disorders, specific contraindication to the execution of a cardiopulmonary test or aerobic
training, recent participation in any physiotherapy/rehabilitation program during 2 months prior to
start of trial
Interventions Aerobic training: Cycle ergometer used with warm-up, endurance and cool-down phases in each 45
min session occurring 3 times per week
Qi-gong: Breathing exercises, stretches, neck and trunk rotation exercises and balance training in the
upright position, 50 minute sessions 3 times per week
Drug regimen remained constant throughout trial period.
Outcomes UPDRS III
UPDRS II
Brown’s disability scale (BDS)
6-minute walk test
Borg scale for breathlessness
Beck depression inventory (BDI)
PDQ-39
Spirometry test
Maximum cardiopulmonary exercise test
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Eligibility Criteria Low risk Inclusion and exclusion criteria stated
Randomisation Method Unclear risk Not stated how random number list was generated
Concealment of Allocation High risk Sealed envelopes
Similarity at Baseline Low risk Group characteristics similar at baseline
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Burini 2006 (Continued)
Intention to Treat Analysis Unclear risk Method of analysis not stated
Withdrawals Described High risk Dropouts at 15%
Cointerventions Constant Low risk Drug regimen remained constant throughout trial
period
Comparable arms Low risk Same time and attention given to both groups
Blinded Assessors Low risk Assessors blinded, patients instructed not to dis-
cuss treatment schedule
Chaiwanichsiri 2011
Methods Parallel group design
Randomisation method not stated
Method of analysis not stated
Treated as outpatients for 3 sessions per week and using home practice for 3 sessions per week each
lasting 30 minutes over 4 weeks plus 4 week home program
Assessed at baseline, immediately after treatment (4 weeks), and after home program at 8 weeks
Assessors were blinded
Participants 10 participants in the treadmill + music + home-walking (TMH) group, 10 participants in the treadmill
and home-walking (TH) group, 10 participants in the home-walking group (H).No dropouts described
Participants’ mean age 67.1 years (TMH group), 67.9 years (TH group), 68.6 years (H group); Male/
female ratio 10/0 (TMH group), 10/0 (TH group), 10/0 (H group); Mean Hoehn and Yahr score 2.
3 (TMH group), 2.5 (TH group), 2.1 (H group); Mean duration of PD 3.7 years (TMH group), 7.4
years (TH group), 4.4 years (H group)
Inclusion criteria: Male, 60-80 years old, PD as diagnosed by attending neurologists, Thai Mental
State Examination > 23, stable medications without freezing, no exercise program in last 2 months,
no contraindication for exercise, H&Y II-III, independent walking without use of gait aids. Exclusion
criteria: Medication change during study, inability to walk on treadmill, cannot complete 80% of
prescribed program
Interventions TMH: 10 minutes of stretching followed by 20 minutes of treadmill training with cueing (music)
delivered 3 days per week and home-walking practised 3 days per week. After treadmill speed was set,
the step frequency would be identified by adjustable electrical metronome. The preparedmusic with the
same rhythmic frequency was chosen. Then the participants were training to walk synchronised with
the matched music rhythm on the treadmill. This music would be recorded in MP3 for the participants
to take home and listen during home practice. Home program consisted of 10 minutes of stretching
and 20 minutes walking. After 4 weeks treadmill training ceased but home program was continued for
a further 4 weeks
TH: 10 minutes of stretching followed by 20 minutes of treadmill training without cueing delivered 3
days per week and home-walking, as described above, practised 3 days per week. After 4 weeks treadmill
training ceased but home program was continued for a further 4 weeks
H: Home-walking practised 6 days per week.
Patients were excluded if medication was changed during trial period. Patients did not participate in
training in 2 months prior to study start
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Chaiwanichsiri 2011 (Continued)






6 metre walk time
Single leg stance
UPDRS I, II, III
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Eligibility Criteria Low risk Inclusion and exclusion criteria stated
Randomisation Method Unclear risk Method not stated
Concealment of Allocation Unclear risk Method of randomisation not stated
Similarity at Baseline Low risk Group characteristics similar at baseline
Intention to Treat Analysis Unclear risk Analysis method not stated
Withdrawals Described Unclear risk Withdrawals not described
Cointerventions Constant Low risk Patients were excluded if medication changed dur-
ing trial period
Comparable arms Unclear risk Home group no therapist time
Blinded Assessors Low risk Assessors were blinded
Dias 2005
Methods Parallel group design
Randomisation method not stated
Method of analysis not stated
Treatment delivered in a total of 20 hour long sessions
Assessed at baseline, immediately after treatment and 30 days after end of treatment
Not stated whether assessors were blinded
Participants 8 participants in the physiotherapy and cardiovascular exercise with visual cues (PTCV) group and 8
in the physiotherapy only (PT) group. No dropouts described
Participants mean age 61.5 years (PTCV group), 64.3 years (PT group); Male/female ratio 4/4 (PTCV
group), 7/1 (PT group); Mean Hoehn and Yahr 1.6 (PTCV group), 1.7 (PT group); Mean duration
29Physiotherapy for Parkinson’s disease: a comparison of techniques (Review)
Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Dias 2005 (Continued)
of PD 7.4 years (PTCV group), 8.4 years (PT group)
Inclusion criteria: Hoehn and Yahr stage ≤3. Exclusion criteria: Any degree of dementia, joint defor-
mations, arthritis, severe pain, other neurological disturbance, submitted to neurological surgery, severe
associated pathologies that would impair physiotherapy
Interventions PTCV: 20 sessions of physiotherapy following a protocol that included 15 mins muscular stretching, 30
mins gait training on stable ground with visual cues, 15 mins cardiovascular exercise using ergometric
bicycle
PT: Conventional physiotherapy.
It was not stated whether drug therapy was kept constant during the trial
Outcomes UPDRS
Functional independence measurement scale
Berg balance scale
Hoehn and Yahr scale
Notes Article in Portuguese
Risk of bias
Bias Authors’ judgement Support for judgement
Eligibility Criteria Low risk Inclusion and exclusion criteria stated
Randomisation Method Unclear risk Method of randomisation not stated
Concealment of Allocation Unclear risk Method of randomisation not stated
Similarity at Baseline Low risk Group characteristics similar at baseline
Intention to Treat Analysis Unclear risk Method of analysis not stated
Withdrawals Described Unclear risk Number of dropouts not stated
Cointerventions Constant Unclear risk Not stated whether drug regimen remained con-
stant throughout trial period
Comparable arms Low risk Same number of sessions of active therapy in both
arms
Blinded Assessors Unclear risk Not stated whether assessors were blinded
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Diehl 2011
Methods Parallel group design
Randomisation method not stated
Analysis method not stated
Treated for 24-36 sessions, lasting 90 mins each over 12 weeks
Assessed at baseline and immediately after treatment
Not stated whether assessors were blinded
Participants 20 participants were recruited, group split not stated. Dropouts not stated
Baseline characteristics not stated but it was reported that no significant differences were found between
groups in pre-test demographic variables
Inclusion and exclusion criteria not stated.
Interventions Group box training: Stretching, lateral foot work, punching various targets, resistance exercises and
aerobic training
Traditional group exercises:Stretching, resistance exercises, aerobic and balance activities
It was not stated whether drug therapy was kept constant during the trial
Outcomes Berg balance scale
Activities-specific balance confidence scale
Functional reach test
Parkinson’s disease quality of life scale
Notes Abstract only
Risk of bias
Bias Authors’ judgement Support for judgement
Eligibility Criteria Unclear risk Eligibility criteria not stated
Randomisation Method Unclear risk Method not stated
Concealment of Allocation Unclear risk Randomisation method not stated
Similarity at Baseline Low risk No significant differences were found between
groups in pretest demographic variables
Intention to Treat Analysis Unclear risk Method of analysis not stated
Withdrawals Described Unclear risk Withdrawals not described
Cointerventions Constant Unclear risk Not statedwhether drug therapywas kept constant
during the trial
Comparable arms Low risk Same time and attention given to both groups
Blinded Assessors Unclear risk Not stated whether assessors were blinded
31Physiotherapy for Parkinson’s disease: a comparison of techniques (Review)
Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Ebersbach 2010
Methods Parallel group design
Randomly allocated by drawing lots
Analysed on a per protocol basis
Treatment took place for 1 hour sessions 4 times per week for 4 weeks
Assessed at baseline and at 16 weeks
Assessors blinded for UPDRS III, not stated for other outcomes
Participants 20 participants in LSVT BIG (BIG) group, 19 participants in Nordic walking (WALK) group and 19
participants in the Home exercise (HOME) group. 1 dropout in WALK group and 1 in HOME group
Participants mean age 67.1 years (LSVT BIG group), 65.5 years (WALK group), 69.3 years (HOME
group); Male/female ratio 7/13 (LSVT-BIG group), 7/12 (WALK group), 8/11 (HOME group); Mean
Hoehn and Yahr 2.8 (LSVT BIG group), 2.6 (WALK group), 2.5 (HOME group); Mean duration of
PD 6.1 years (LSVT-BIG group), 7.8 years (WALK group), 7.4 years (HOME group)
Inclusion criteria: Fulfil diagnostic criteria for IPD, Hoehn & Yahr stage I-III outpatient treatment,
stable medication 4 weeks prior to inclusion. Exclusion criteria: Dementia (MMSE<25), severe depres-
sion, disabling dyskinesias, comorbidity affecting mobility or ability to exercise
Interventions LSVT BIG: 50% of exercises consisted of standardized whole-body movements with maximal am-
plitude, repetitive multidirectional movements and stretching. 50% of exercise included goal-directed
ADL according to individual needs and preferences. ADL were performed using high amplitude LSVT
BIG movements. LSVT BIG was delivered one-to-one with intensive motivation and feedback. Par-
ticipants were constantly encouraged to work with at least ‘80% of their maximal energy’ on every
repetition and taught to use bigger movements in routine activities to provide continuous exercise in
everyday movements. Participants in all groups were encouraged to exercise regularly at home. Diaries
were used to document type and duration of exercise performed in addition to supervised LSVT BIG
WALK: Each session consisted of a standardized protocol for beginners including warming up, prac-
ticing Nordic walking and finally a cooling down. Sessions were performed in a local park in groups of
4 or 6 and constantly supervised by the therapist. Participants in all groups were encouraged to exercise
regularly at home. Diaries were used to document type and duration of exercise performed in addition
to supervised WALK sessions
HOME: 1 hours instruction of domestic training with practical demonstration and training. Exercises
included stretching, high-amplitude movements, as well as active workouts for muscular power and
posture. Participants in all groups were encouraged to exercise regularly at home. They received a diary
to document type and duration of exercise performed
Changes in medication occurred in 6 patients from each group
Outcomes UPDRS III
PDQ-39
Timed up and go
Time to walk 10 m
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Eligibility Criteria Low risk Inclusion and exclusion criteria stated
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Ebersbach 2010 (Continued)
Randomisation Method High risk Randomised by drawing lots
Concealment of Allocation High risk Randomised by drawing lots
Similarity at Baseline Low risk Group characteristics similar at baseline
Intention to Treat Analysis Unclear risk Analysed on a per protocol basis
Withdrawals Described Low risk Withdrawals <10%
Cointerventions Constant Unclear risk Minor changes to medication
Comparable arms Unclear risk Time and attention greater in LSVT BIG and
WALK groups than in HOME group
Blinded Assessors Unclear risk Assessors blinded for primary outcome, not stated
for secondary outcomes
Fisher 2008
Methods Parallel group design
Subjects closed their eyes and selected a card corresponding to 1 of the 3 groups
Analysis method not stated
Treated as outpatients for 24 sessions over 8 weeks for both treatment arms, 6 sessions over 8 weeks for
control group
Assessed at baseline and immediately post-treatment
Assessors were blinded
Participants 10 participants in treadmill group, 10 participants in physiotherapy group and 10 in the control arm.
No dropouts
Participants’ mean age, 64.0 years (treadmill), 61.5 years (physiotherapy), 63.1 years (control). Male/
female ratio, 6/4 (treadmill), 5/5 (physiotherapy), 8/2 (control). Mean Hoehn and Yahr 1.9 in all 3
groups. Mean duration of PD 1.2 years (treadmill), 0.7 years (physiotherapy), 1.5 years (control)
Inclusion criteria: Early stage PD, diagnosis of PDwithin 3 years of study participation,Hoehn andYahr
stage 1 or 2, 18 years or older, medical clearance from primary care physician to participate in exercise
programme, ability to walk. Exclusion criteria: Medical or physical screening examination showed a
score of less than 24 on the MMSE, there were physician determined major medical problems such
as cardiac dysfunction that would interfere with participation, they had musculoskeletal impairments
or excessive pain in any joint that could limit participation in an exercise programme, had insufficient
endurance and stamina to participate in exercise 3 times per week for a 1 hour session
Interventions Treadmill: Level of intensity was defined by metabolic equivalents (MET). High intensity exercise
greater than 3 METs. Body weight supported (BWS) treadmill training. Goal of each session was to
reach and maintain a MET > 3. Exercise progressed by decreasing BWS (initially 10% of participants’
bodyweight) and physical assistance, increasing the treadmill speed and time on the treadmill, with the
end goal for each participant to walk on the treadmill continuously for 45 min within the MET range
Physiotherapy: Less than 3 METs. This group was representative of general or traditional physical
therapy. Each 45 min session was individualised and consisted of activities from 6 categories 1) passive
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Fisher 2008 (Continued)
range of motion and stretching 2) active range of motion 3) balance activities 4) gait 5) resistance
training 6) practice of functional activities and transitional movements
Control: Zero intensity group. Six 1 hour education classes taken over an 8 week period
All participants were allowed to continue their customary exercise routines and filled out a daily exercise
diary
Drug therapy was constant during the trial.
Outcomes UPDRS (Total, I, II and III subscores)
Hoehn and Yahr
Functional assessments
Walking tests: average gait velocity, step length, stride length, cadence, double limb support time, ankle,
knee, hip rotation
Sit-to-stand test
Transcranial magnetic stimulation (subset)
All participants took their customary medications at the same time relative to each assessment
Notes Control arm not included in this review
Risk of bias
Bias Authors’ judgement Support for judgement
Eligibility Criteria Low risk Inclusion and exclusion criteria stated
Randomisation Method High risk Subjects self-selected a card with eyes closed
Concealment of Allocation High risk Subjects self-selected a card with eyes closed
Similarity at Baseline Low risk Group characteristics similar at baseline
Intention to Treat Analysis Unclear risk Method of analysis not described
Withdrawals Described Low risk No dropouts
Cointerventions Constant Low risk All medication kept stable during course of study
Comparable arms Low risk Same time and attention given to participants in
both arms
Blinded Assessors Low risk Assessors were blinded to group allocation
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Frazzitta 2009
Methods Parallel group design
Randomisation method not stated
Analysis method not stated
Treatment was delivered over 4 weeks in 28 sessions lasting 20 mins each
Assessed at baseline and immediately after treatment
Not stated whether assessors were blinded
Participants 20 participants in treadmill with cues group, 20 in Auditory and visual cues group. No dropouts
Participants mean age 71 years for both groups; Male/female ratio not stated; Mean Hoehn and Yahr
3 for both groups; Mean duration of condition 13.2 years (treadmill group), 12.9 years (cued group)
Inclusion criteria: Clinically probable IPD, ability to walk without assistance, visual and hearing capac-
ity sufficient to perceive the cues, freezing of gait at the time of peak medication, stable pharmacological
treatment, Hoehn & Yahr stage III, no cognitive impairment, MMSE > 26. Exclusion criteria: Neu-
rological condition other than IPD, postural hypertension, cardiovascular disorders, musculoskeletal
disorders, vestibular dysfunction limiting locomotion or balance
Interventions Treadmill: Rehabilitation protocol for gait disturbance& freezing that used treadmill training associated
with auditory & visual cues. Maximum tolerated walking speed -40% used for 2 day warm-up, then
increased by 0.05 stride cycles/second. Visual cue of target on screen that participant had to reach with
stride, auditory cue of music at matched frequency
Cued: Visual cue of lines spaced according to individual stride length for gait training coupled with
auditory cue of music at frequency matching that used in Treadmill group
It was not stated whether drug therapy was kept constant during the trial
Outcomes UPDRS III
Gait speed
Freezing of gait questionnaire
Stride length
6 minute walking test
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Eligibility Criteria Low risk Inclusion and exclusion criteria stated
Randomisation Method Unclear risk Method not stated
Concealment of Allocation Unclear risk Randomisation method not stated
Similarity at Baseline Low risk Group characteristics similar at baseline
Intention to Treat Analysis Unclear risk Method of analysis not stated
Withdrawals Described Low risk No dropouts
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Frazzitta 2009 (Continued)
Cointerventions Constant Unclear risk Not stated whether drug regimen remained con-
stant throughout trial period
Comparable arms Low risk Same time and attention given to participants in
both arms
Blinded Assessors Unclear risk Not stated whether assessors were blinded
Hackney 2007
Methods Parallel group design
Randomisation method not stated
Method of analysis not given
Treated as outpatients for 20 sessions each lasting 1 hour delivered over 13 weeks
Assessed 1 week prior to treatment and 1 week after treatment
Assessors were blinded
Participants 9 participants in Tango group, 10 in Exercise group. No dropouts were reported
Participants mean age 72.6 years (Tango), 69.6 years (exercise); Male/female ratio 6/3 (Tango), 6/4
(exercise); Hoehn and Yahr 2.3 (Tango), 2.2 (exercise); Mean duration of condition 6.2 years (Tango),
3.3 years (exercise)
Inclusion criteria: Diagnosed with clinically defined IPD, clear benefit from PD medications
Interventions Tango: Progressive Tango dance lessons with postural stretches, balance exercises, Tango-style, footwork
patterns and experimentation with timing of steps to music with and without partner
Exercise: Structured flexibility exercise classes designed for people with PD and/or elderly individuals.
Breathing and stretching exercises progressed to resistance and dexterity exercises sometimes using water
bottles or yard sticks to provide resistance or leverage. Some exercises done standing or using chair for
support and last 10 minutes consisted of core strengthening exercises using floor matts or modified
exercises in chair




Timed up and go
Velocity of walking and dual-task walking
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Eligibility Criteria Low risk Inclusion criteria stated, clear definition of disease
Randomisation Method High risk Numbers drawn from a hat
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Hackney 2007 (Continued)
Concealment of Allocation High risk Numbers drawn from a hat
Similarity at Baseline Low risk Group characteristics similar at baseline
Intention to Treat Analysis Unclear risk Method of analysis not given
Withdrawals Described Low risk No dropouts reported
Cointerventions Constant Low risk Drug regimen remained constant throughout trial
period
Comparable arms Low risk Same time and attention given to participants in
both arms
Blinded Assessors Low risk Assessors were blinded
Hackney 2009
Methods Parallel group design
Randomised by selecting allocation from a hat, carried out by trial investigator
Method of analysis not given
Treatment delivered in 1 hour sessions twice weekly for a total of 20 sessions
Assessed at baseline and within 1 week of completing 20 classes
Assessors were blinded
Participants 19 participants in tango group, 19 inWaltz/Foxtrot group , 17 in Tai Chi and 20 in control. 5 dropouts
in Tango group, 2 dropouts in Waltz/Foxtrot, 4 dropouts in Tai Chi and 3 in control group
Participants mean age 68.2 years (Tango group), 66.8 years (Waltz/Foxtrot group), 64.9 (Tai Chi), 66.5
(control); Male/female ratio 11/3 (Tango group), 11/6 (Waltz/Foxtrot), 11/2 (Tai Chi),12/5 (control)
; Hoehn & Yahr 2.1 (Tango), 2.0 (Waltz/Foxtrot), 2.0 (Tai Chi), 2.2 (control); Mean duration of
condition 6.9 years (Tango), 9.2 years (Waltz/Foxtrot), 8.7 (Tai Chi), 5.9 (control)
Inclusion criteria: At least 40 years of age, could stand for at least 30 min, could walk independently 3
or more metres with or without assistive device, diagnosis of IPD using diagnostic criteria for critically
defined “definite PD” based upon published standards, patients demonstrated clear benefit from L-
dopa, Hoehn & Yahr I-III. Exclusion criteria: History of neurological deficit other than PD, patients
had been previously screened for dementia by their neurologists and nonewere diagnosedwith dementia
Interventions Waltz/Foxtrot and Progressive Tango: Experience professional ballroom dancer taught progressive
Tango, Waltz/Foxtrot lessons. Instructor, equally versed in both dances, attempted to give all students
equal time in leading and following dance roles. All steps done in closed practice position, participants
maintain contact through upper extremities and face one another
Tai Chi: Progressive lessons on Tai Chi’s 1st and 2nd circles of the Yang short style of Cheng Manching
taught by experienced instructor
Control: No intervention.
Drug therapy was constant during the trial or patients were excluded
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Timed up and go test
One leg stance test
6 minute walk test
Gait
Notes Control arm not included in this review
Risk of bias
Bias Authors’ judgement Support for judgement
Eligibility Criteria Low risk Inclusion and exclusion criteria stated
Randomisation Method High risk Allocation pulled out of hat
Concealment of Allocation High risk Allocation pulled out of hat
Similarity at Baseline Low risk Group characteristics similar at baseline
Intention to Treat Analysis Unclear risk Method of analysis not given
Withdrawals Described High risk Withdrawals at 19%
Cointerventions Constant Low risk Patients excluded if change in medication was re-
quired
Comparable arms Low risk Same time and attention given to both groups
Blinded Assessors Low risk Assessors blinded
Hackney 2010
Methods Parallel group design
Randomised by selecting allocation from a hat
Analysed on an intention-to-treat basis
Treatment was delivered in 1 hour classes twice a week for 10 weeks
Assessed in the week prior to start of treatment, the week following completion of 10 week treatment
and 4 weeks after completion of treatment
Assessors were blinded
Participants 19 participants in the partnered tango group, 20 in the non-partnered tango group. 7 dropouts in
partnered group, 5 in non-partnered group
Participants mean age 69.6 years in both groups; Male/female ratio 13/6 (partnered), 15/5 (non-
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Hackney 2010 (Continued)
partnered); Mean Hoehn and Yahr 2.5 (partnered) 2.0 (non-partnered); Duration of condition 9.5
years (partnered), 7.9 years (non-partnered)
Inclusion criteria: PD without a history of other neurological deficits, at least 40 years of age, able to
stand for at least 30 minutes and walk independently for 3 or more metres with or without an assistive
device, diagnosis of IPD Hoehn and Yahr stages I-III using diagnostic criteria for clinically defined
’definite PD’ and demonstrated clear benefit from L-dopa. Exclusion criteria not stated
Interventions Both partnered and non-partnered groups began with identical warm-ups to upbeat latin music. After
warm-up both classes listened to and danced to identical commercial tango music selections in the same
order of presentation
Partnered: both sexes spent equal time leading and following dance steps, performed in a ‘closed practice’
position, an adaptation of the traditional ballroom frame. Participants with PD always danced with
individuals without PD. These individuals included caregivers and loved ones who elected to participate
in classes as well as young adult volunteers
Non-partnered: learned the same Argentine ‘leading’ and ‘following’ tango-based steps as the partner
group but performed them without a partner. Caregivers, loved ones and volunteers participated in the
nonpartner class also
Participants remained on a steady drug regimen throughout the study
Outcomes Tandem stance
One leg stance
Timed up and go








Bias Authors’ judgement Support for judgement
Eligibility Criteria Low risk Inclusion criteria stated
Randomisation Method High risk Randomised by selecting allocation from a hat
Concealment of Allocation High risk Randomised by selecting allocation from a hat
Similarity at Baseline Low risk Group characteristics similar at baseline
Intention to Treat Analysis Unclear risk Analysed on an intention-to-treat basis
Withdrawals Described High risk Withdrawals at 31%
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Hackney 2010 (Continued)
Cointerventions Constant Low risk Participants remained on a steady drug regimen
throughout the study
Comparable arms Low risk Same time and attention given to participants in
both arms
Blinded Assessors Low risk Assessors were blinded
Hass 2006
Methods Parallel group design
Randomisation method not stated
Analysis method not stated
Treatment delivered in 1 hour sessions twice a week for a total of 32 sessions
Assessment intervals not stated
Investigators were blinded
Participants 23 participants were recruited into the study. Number of dropouts was not stated
Baseline characteristics for groups not stated. Total mean age 67 years; Hoehn Yahr 2.2
Inclusion criteria: IPD. Exclusion criteria not stated.
Interventions Tai Chi: Emphasised physical movements, mind/body coordination & meditation. 8 forms of Tai Chi
performed in sessions
Qi-gong: Emphasised prolonged intense contemplative or deep meditation in 2 postures, seated or
lying supine on floor mats









Bias Authors’ judgement Support for judgement
Eligibility Criteria Unclear risk Inclusion criteria IPD only
Randomisation Method Unclear risk Method not stated
Concealment of Allocation Unclear risk Method of randomisation not stated
Similarity at Baseline Unclear risk Baseline characteristics not split by group
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Hass 2006 (Continued)
Intention to Treat Analysis Unclear risk Method of analysis not stated
Withdrawals Described Unclear risk Withdrawals not described
Cointerventions Constant Unclear risk Not stated whether drug therapies were kept con-
stant throughout trial period
Comparable arms Low risk Same time and attention given to participants in
both arms
Blinded Assessors Low risk Single blind study
Hirsch 1996
Methods Parallel group design
Randomised according to a computer generated random number list but concealment of allocation not
stated
Analysed on a per protocol basis
Treated as outpatients for an unspecified period of time (3 days/week) for 10 weeks
Assessed at baseline, immediately after treatment and 4 weeks later
Assessors were not blinded
Participants 6 patients in novel combined balance and resistance training group and 9 patients in balance training
group. No dropouts stated.
Patients mean age 70.8 years (combined), 75.7 years (balance);Male/female ratio not stated; Hoehn and
Yahr 1.8 (combined), 1.9 (balance); Duration of condition 5.5 years (combined), 8.3 years (balance).
Inclusion criteria: Diagnosed with IPD by neurologist, not participated in any organised balance or
muscle strengthening activities before being pre-tested, ambulatory, not acutely ill, able to follow simple
commands, not suffering from unstable cardiovascular disease.
Exclusion criteria: Uncontrolled chronic conditions that would interfere with safety and conduct of
the training and testing
Interventions Combined: Group training in strengthening and balance exercises. Resistance exercises used Nautilus
leg extension and side-lying leg-flexion machines and therabands. Balance training consisting of gentle
sternal or dorsal perturbation and leaning movements designed to enhance limit of stability whilst
standing on a firm or a compliant surface.
Balance: ’standard’ group balance therapy as described above.
Medications kept stable throughout trial period.
Outcomes Balance
Muscle strength (subset) : knee extensors, knee flexors, ankle plantar flexors
Latency to fall
% of trials resulting on falls
Notes Randomisation violation; 1 patient who was allocated to the combined therapy group was reassigned
to the balance group after 2 weeks of training due to an inguinal hernia making it impossible for him
to carry out the strength training
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Hirsch 1996 (Continued)
Risk of bias
Bias Authors’ judgement Support for judgement
Eligibility Criteria Low risk Inclusion and exclusion criteria stated
Randomisation Method Low risk Computer generated random number list
Concealment of Allocation Unclear risk Method not stated
Similarity at Baseline Low risk Group characteristics similar at baseline
Intention to Treat Analysis Unclear risk Per protocol analysis
Withdrawals Described Low risk 13%withdrawal rate formuscle strength outcomes
only
Cointerventions Constant Low risk Medications kept stable throughout trial period
Comparable arms Low risk Same time and attention given to participants in
both arms
Blinded Assessors High risk Assessors not blinded
Joudoux 2011
Methods Parallel group design
Randomisation method not stated
Analysis method not stated
Treated for 3 weekly 1 hour sessions for 8 weeks
Assessed at baseline, after treatment and after 3 months follow-up
Not stated whether assessors were blinded
Participants 50 participants recruited, group split not stated. Dropouts not stated
Patients baseline characteristics not stated.
Inclusion criteria: Mild to moderate PD (Hoehn and Yahr II-III). Exclusion criteria not stated
Interventions Assymmetric motor training Program: Designed to enhance only the agonist activity of the ’body open-
ers’ i.e. extension/supination/abduction/external rotation - which is more reduced than their antago-
nist activity of flexion/protonation/adduction/internal rotation in PD - aiming at re-balancing forces
around joints
Broad program: Standard techniques of passive and active joint mobilisations, balance and gait training,
relaxation techniques and respiratory techniques and respiratory work
Not stated whether drug regimen remained constant throughout trial period
Outcomes UPDRS III
GMT score
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Joudoux 2011 (Continued)
Rapid alternating movements
Hand writing and spiralography
PDQ-39
Dpression (GDS-15)
Video recording of 8 activities of daily living and biomechanical evaluations
Notes Abstract only
Risk of bias
Bias Authors’ judgement Support for judgement
Eligibility Criteria Unclear risk Inclusion and exclusion criteria stated
Randomisation Method Unclear risk Method not stated
Concealment of Allocation Unclear risk Randomisation method not stated
Similarity at Baseline Unclear risk Group characteristics not stated
Intention to Treat Analysis Unclear risk Method of analysis not stated
Withdrawals Described Unclear risk No dropouts described
Cointerventions Constant Unclear risk Not stated whether drug regimen remained con-
stant throughout trial period
Comparable arms Low risk Same time and attention given to participants in
both arms
Blinded Assessors Unclear risk Not stated whether assessors were blinded
Juncos 2006
Methods Parallel group design
Method of randomisation not stated
Analysed on an intention-to-treat basis
Treated for 6 months
Assessed at baseline then monthly and after last training session
Assessors were blinded
Participants 56 participants were randomised into Aerobic exercise (AE), Tai Chi Chung (TCC) or Qi Gong (QG)
groups. 16 dropouts in total. Group splits not stated
Baseline characteristics for groups not stated. Total mean age 65 years
Inclusion criteria: Ambulatory subjects with IPD, stable medication regimen, MMSE > 24/30. Exclu-
sion criteria not stated
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Juncos 2006 (Continued)
Interventions AE: Moderate intensity walk-run program with moderate caloric expenditure
TCC: Intermediate intensity to that of AE, low caloric expenditure
QG: Meditation in stillness, minimal caloric expenditure.








Notes Abstract and trial registration only
Risk of bias
Bias Authors’ judgement Support for judgement
Eligibility Criteria Low risk Inclusion criteria stated
Randomisation Method Unclear risk Method not stated
Concealment of Allocation Unclear risk Method of randomisation not stated
Similarity at Baseline Unclear risk Hoehn and Yahr not stated
Intention to Treat Analysis Unclear risk Intention-to-treat analysis used
Withdrawals Described High risk Withdrawals to 29%
Cointerventions Constant Low risk Drugs stable during therapy
Comparable arms Low risk Same time and attention given to both groups
Blinded Assessors Low risk Assessors were blinded
Khallaf 2011
Methods Parallel group design
Randomisation method not stated
Analysis method not stated
Treatment dose not stated
Assessment intervals not stated
Not stated whether assessors were blinded
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Khallaf 2011 (Continued)
Participants 15 participants in Physiotherapy and treadmill group (PT + T) and 15 in Physiotherapy only group
(PT). Dropouts not described
Participant baseline characteristics not stated.
Inclusion/exclusion criteria not stated.
Interventions PT + T: Designed physiotherapy program in addition to 20 min of treadmill training
PT: Designed physiotherapy program only.
Not stated whether drug therapies were kept constant throughout trial period
Outcomes UPDRS II and III
Hamilton rating scale of depression
Walking speed
Walking distance
Notes Abstract only, no contact details found for author
Risk of bias
Bias Authors’ judgement Support for judgement
Eligibility Criteria Unclear risk Inclusion criteria not stated
Randomisation Method Unclear risk Method not stated
Concealment of Allocation Unclear risk Method of Randomisation not stated
Similarity at Baseline Unclear risk Participant baseline characteristics not stated
Intention to Treat Analysis Unclear risk Method of analysis not stated
Withdrawals Described Unclear risk Dropouts not described
Cointerventions Constant Unclear risk Not stated whether drug therapies were kept con-
stant throughout trial period
Comparable arms Unclear risk No details of intervention schedules
Blinded Assessors Unclear risk Not stated whether assessors were blinded
45Physiotherapy for Parkinson’s disease: a comparison of techniques (Review)
Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Li 2012
Methods Parallel group design
Randomised by permuted blocks, allocation delivered in sealed envelopes
Analysed on an intention-to-treat basis
Treatment delivered in 2 sessions per week each lasting an hour over 24 weeks
Assessed at baseline and post intervention (at 6 months) and at 3 months follow-up
Assessors were blinded
Participants 65 participants in Tai Chi group, 65 in resistance group, 65 in the stretching group. 9 dropouts in Tai
Chi group, 6 in resistance group, 4 in stretching group
Participants mean age 68 years (Tai Chi), 69 years (resistance), 69 years (stretching); Male/female ratio
45/20 (Tai Chi), 38/27 (resistance), 39/26 (stretching); Mean Hoehn and Yahr not given; Duration of
condition 8 years (Tai Chi), 8 years (resistance), 6 years (stretching)
Inclusion criteria: Clinical diagnosis of PD, aged 40 - 85 years, Hoehn and Yahr stage I - IV, at least one
score of at least 2 or more for at least one limb for the tremor, rigidity, postural stability or bradykinesia
items in the motor section of the UPDRS, stable medication use, ability to stand unaided and walk
with or without an assistive device, medical clearance for participation and willingness to be assigned
to any of the three interventions. Exclusion criteria: Current participation in any other behavioural
or pharmacologic study or instructor led exercise program, a MMSE score lower than 24, debilitating
conditions or vision impairment that would impede full participation in the study, unavailability during
the study period
Interventions Tai Chi: Six Tai Chi movements integrated into an eight-form routine. The protocol was specifically
designed to tax balance and gait by having participants perform symmetric and diagonal movements,
such as weight shifting, controlled displacement of the centre of mass over the base of support, ankle
sways an anterior -posterior and lateral stepping. The first 10 weeks emphasized the mastery of single
forms through multiple repetitions; later weeks focused on repetitions to enhance balance and increase
locomotion. Natural breathing was integrated into the training routine
Resistance: Focused on strengthening the muscles that are important for posture, balance and gait.
Resistance (with weighted vests and ankle weights) was introduced at week 10. Weight vest resistance
was initially set at 1% of body weight and was increased by approx. 1 to 2% of body weight, depending
on each participants tolerance, every fifth week until 5% of body weight was achieved. Ankle weights
started at 0.45 Kg per limb and were gradually increased to 1.36 Kg. the routine involved 8 to 10
exercises, including forward and side steps, squats, forward and side lunges, and heel and toe raises,
performed in 1 to 3 sets of 10 to 15 repetitions. Progression was modified for participants with physical
limitations. Natural breathing was emphasized during the training routine
Stretching: This control condition was designed to provide a low intensity exercise program with the
social interaction and enjoyment inherent in the two other interventions but without similar training
benefits in lower-extremity weight bearing, strength or balance. The core activities encompassed a
variety of seated and standing stretches involving the upper body (neck, upper back, shoulders, chest
and arms) and lower extremities (quadriceps, hamstrings, calves and hips) with the use of gentle joint
extension and flexion and trunk rotation. Abdominal breathing with an emphasis on inhaling and
exhaling to maximum capacity and relaxation of major muscle were also included
There were no significant changes reported in outside physical activity or use of anti-parkinsonian
medication
Outcomes Two indicators of postural stability: maximum excursion and directional control
Stride length
Walking velocity
Strength of bilateral knee extensors and flexors
Functional reach test
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Li 2012 (Continued)
Timed up and go
UPDRS III
Number of falls
Notes 122/195 participants continued with their exercise out to 3 month follow-up so this is not a clean
follow up comparison
Stretching arm classed as attention control and not included in this review
Risk of bias
Bias Authors’ judgement Support for judgement
Eligibility Criteria Low risk Inclusion and exclusion criteria stated
Randomisation Method Unclear risk Permuted blocks
Concealment of Allocation High risk Sealed envelopes used
Similarity at Baseline Unclear risk Mean Hoehn and Yahr not given
Intention to Treat Analysis Low risk Intention-to-treat analysis used
Withdrawals Described Low risk Withdrawals <10%
Cointerventions Constant Unclear risk No significant change in medications
Comparable arms Low risk Same time and attention given to each group
Blinded Assessors Low risk Assessors blinded
Loureiro 2010
Methods Parallel group design
Randomisation method not stated
Analysis method not stated
Treatment delivered in 2 sessions per week over 6 weeks
Assessment intervals not stated
Not stated whether assessors were blinded
Participants 6 participants in conventional physiotherapy (Physio) group, 6 in complimentary activities (CA) group
Mean age 57 (Physio group), 65 (CA group).
Inclusion criteria: Hoehn and Yahr II-III. Exclusion criteria not stated
Interventions Physio: Conventional physiotherapy.
CA: Wii fit in addition to conventional physiotherapy.
Not stated whether the drug therapy was constant during trial
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Loureiro 2010 (Continued)




Bias Authors’ judgement Support for judgement
Eligibility Criteria Low risk Inclusion criteria stated
Randomisation Method Unclear risk Method not stated
Concealment of Allocation Unclear risk Method of randomisation not stated
Similarity at Baseline Unclear risk Hoehn and Yahr not stated
Intention to Treat Analysis Unclear risk Method of analysis not stated
Withdrawals Described Unclear risk Dropouts not described
Cointerventions Constant Unclear risk Not stated whether drug therapies were kept con-
stant throughout trial period
Comparable arms Low risk Same time and attention given to participants in
both arms
Blinded Assessors Unclear risk Not stated whether assessors were blinded
Mak 2008
Methods Parallel-group design
Participants randomly allocated to groups by drawing lots
Method of analysis not described
Treated as outpatients for 4 hours (audio-visual), 6 hours (exercise) over 4 weeks
Assessed at baseline, at 2 weeks, immediately after and 2 weeks after treatment had ended
Assessor was blinded
Participants 21 participants in the cueing group, 21 participants in the exercise group and 18 in the control group.
2 dropouts from the cueing group, 2 from the exercise group and 4 from the control group
No baseline characteristics given for drop-outs. Participants’ mean age 63 (cueing), 66 (exercise), 63
(control). No data given for the sex of participants. Hoehn and Yahr stage 2.8 (cueing), 2.7 (exercise)
and 2.7 (control). Duration of PD 5.9 years (cueing), 6.1 years (exercise), 5.9 years (control)
Inclusion criteria: diagnosed with PD according to Quinn, stable on anti-PD medications without
dyskinesia, orthopaedic, arthritic or heart problems, aged between 50-75 years old, perform sit to stand
independently, can follow instructions. No exclusion criteria stated
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Mak 2008 (Continued)
Interventions Cueing: Audio-visual cued task-specific training for 20 min three times per week. Received cued sit-to-
stand training using Equitest-Balance Master. Visual cue was given on a computer screen with verbal
command as auditory cue. Each task lasted 2 min, repeated once with a 30 second rests in between
Exercise: 45 min of conventional exercise twice a week. Conventional mobility and strengthening
exercises for flexors and extensors of trunk, hips, knees and ankles followed by sit-to-stand practice
Control: No treatment.
Drugs stable during therapy.
Outcomes Peak horizontal velocity
Peak vertical velocity
Movement time
3D Kinematics data of sit-to-stand
Not stated when during the day tests took place
Notes Control group not included in this review
Risk of bias
Bias Authors’ judgement Support for judgement
Eligibility Criteria Low risk Inclusion criteria stated
Randomisation Method High risk Participants randomised by drawing lots
Concealment of Allocation High risk Participants randomised by drawing lots
Similarity at Baseline Low risk Group characteristics similar at baseline
Intention to Treat Analysis Unclear risk Method of analysis not stated
Withdrawals Described High risk Withdrawals at 13%
Cointerventions Constant Low risk Medications kept stable throughout trial period
Comparable arms Low risk Same time and attention given to participants in
both arms
Blinded Assessors Low risk Assessors blinded
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McGinley 2012
Methods Parallel group design
Method of randomisation not stated
Analysed on an intention-to-treat basis
Treated as outpatients for a 2 hour session once per week for 8 weeks plus home practice
Assessed at baseline, one week after intervention, at 3 months and 12 months after intervention
Assessors blinded.
Participants 69 participants in Movement strategy training group (MST), 70 in Progressive strength training group
(PST), 71 in Life-skills control group (LS). 14 dropouts prior to post-intervention time point
Baseline characteristics not split by group. Participants mean age 67.9 years; Male/female ratio 140/70;
Hoehn and Yahr mean score not stated; Duration of condition 6.7 years
Inclusion criteria: Confirmed Idiopathic Parkinson’s disease, Hoehn & Yahr stages 0-4, able to partici-
pate in an outpatient exercise program including strength training, willing to complete a falls calendar
for 12 months after therapy, able to walk, willing and able to attend the therapy and assessment pro-
gram. Exclusion criteria: Score less than 24 on mini-mental state examination, rating greater than 4 on
the modified Hoehn & Yahr scale, on major tranquillisers, other medical conditions that could limit
or prevent exercising safely at the required intensity, other prior neurological conditions affecting and
dementia
Interventions MST:Movement strategies emphasise task specific practice of everyday functional actions such as rolling
over, standing up, walking, crossing obstacles and turning. These tasks are practised with strategies such
as visual or auditory cues, mental rehearsal and movement planning, conscious attention during the
task and breaking the task into a sequence of smaller components. The program is tailored tomovement
impairments, activity limitations, and cognitive status and learning ability
An individualised home practice session of strategies to practice within the home or community will be
completed once a week. Structured falls risk education will also be provided each week. A single home
visit will be conducted by a trained therapist or nurse to check compliance with the therapy program
PST: Strengthening exercises for quadriceps, hip and trunk extensor muscles, hip abductors, calf, and
ankle dorsiflexors, tailored to individual’s strength and functional ability. Where possible training is
performed in functional tasks such as standing up from a chair, stepping up onto a step etc, using body
weight, weighted vests and Thera-band® to progress the resistance. Structured falls risk education will
be provided each week. An individualised home practice session of strengthening exercises will also be
completed once a week. A single home visit will be conducted by a trained therapist or nurse to check
compliance with the therapy program
LS: Equivalent duration to theMST and PST groups. Each session led byOTs, PTs, Speech pathologists
or social workers and included content such as relaxation, games, or communication activities. Guided
discussion. Guided discussion will also include topics such as the impact of PD on the individual and
family, support and resources available and fatigue management. None of the content will relate to
walking, balance or falls risk education. A home session of reflection activities and relaxation practice
will also be completed once per week
Not stated whether the drug therapy was constant during treatment
Outcomes Falls: no. of fallers per group, no. of multiple fallers per group, falls rate over 12 months in each group
Number of injurious falls
Walking speed
6 minute walk test
Timed up and go
UPDRS II and III
PDQ-39
EuroQol-5D
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McGinley 2012 (Continued)
Notes LS arm not included in this review
Risk of bias
Bias Authors’ judgement Support for judgement
Eligibility Criteria Low risk Inclusion and exclusion criteria stated
Randomisation Method Unclear risk Method not stated
Concealment of Allocation Unclear risk Method of randomisation not stated
Similarity at Baseline Unclear risk Baseline characteristics not split into groups
Intention to Treat Analysis Low risk Analysed on an intention-to-treat basis
Withdrawals Described Low risk Withdrawals at 7% for post-intervention time
point
Cointerventions Constant Unclear risk Not stated whether the drug therapy was constant
during treatment
Comparable arms Low risk Same time and attention given to participants in
each physio group
Blinded Assessors Low risk Assessors were blinded
Miyai 2000
Methods Cross-over design
Randomisation using the envelope method
Analysed on an intention-to-treat basis
Inpatients treated for 12 sessions, each lasting 45 minutes, over 4 weeks
Assessed at baseline, after first set of treatment at 4 weeks and after second set of treatment at 8 weeks
Assessors were not blinded
Participants 5 participants in body-weight supported treadmill training (BWSTT) and 5 in conventional physio-
therapy (PT). No dropouts described
Participants mean age 66 years (BWSTT), 69.3 years (PT); Male/female ratio 2/3 (BWSTT), 3/2 (PT)
; Hoehn and Yahr 2.8 (BWSTT), 2.9 (PT); Duration of condition 4.9 years (BWSTT), 3.6 years (PT)
Inclusion criteria:Hoehn andYahr stage 2.5 or 3Parkinson’s disease, nodementiaMMSE>27. Exclusion
criteria not stated
Interventions BWSTT:Walkingwith 20%bodyweight support (BWS) for 12minutes, then 4.5minutes rest, followed
by 10% BWS for 12 minutes, another 4.5 minutes rest and finally 12 minutes walking with 0% BWS.
Walking speed started at 0.5 km/hr and was ramped up in 0.5 km/hr increments to 3.0 km/hr as
tolerated
PT: General conditioning, range of motion exercise, activities of daily living training and gait training
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Miyai 2000 (Continued)
Drug therapy was stable during trial period.
Outcomes UPDRS
UPDRS subscales (mental, ADL, motor and complications)
Overground ambulation endurance
Gait speed
No. steps taken for 10 metre walk
Notes Pre-crossover data only used
Risk of bias
Bias Authors’ judgement Support for judgement
Eligibility Criteria Low risk Inclusion criteria stated
Randomisation Method Unclear risk Method not stated
Concealment of Allocation High risk By the envelope method
Similarity at Baseline Low risk Group characteristics similar at baseline
Intention to Treat Analysis Low risk Analysed on an intention-to treat basis
Withdrawals Described Low risk No withdrawals
Cointerventions Constant Low risk Drug therapy was stable during therapy period
Comparable arms Low risk Same time and attention given to participants in
both arms
Blinded Assessors High risk Assessors were not blinded
Miyai 2002
Methods Parallel group design
Randomisation was the envelope method
Analysed on an intention-to-treat basis
Treatment delivered for 12 sessions over 1 month, sessions lasted 45 minutes
Assessed at baseline, at 1 month, 2 months, 3 months, 4 months, 5 months and 6 months
Assessors were not blinded
Participants 11 participants in body-weight supported treadmill training (BWSTT) group and 9 in conventional
physiotherapy (PT) group. 4 participants not analysed due to changes in their medication
Participants mean age 69.5 years (BWSTT), 69.8 years (PT); Male/female ratio 5/6 (BWSTT), 5/4
(PT); Hoehn and Yahr 2.9 (BWSTT), 2.8 (PT); Duration of condition 4.1 years (BWSTT), 4.5 years
(PT).
Inclusion criteria: Diagnosis of Parkinson’s disease based on the presence of rest tremor, bradykinesia,
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Miyai 2002 (Continued)
rigidity, positive response to l-dopa and no evidence of vascular lesions on MRI. Hoehn and Yahr stage
2.5 or 3. Exclusion criteria: Dementia, MMSE <27
Interventions BWSTT:Walkingwith 20%bodyweight support (BWS) for 12minutes, then 4.5minutes rest, followed
by 10% BWS for 12 minutes, another 4.5 minutes rest and finally 12 minutes walking with 0% BWS.
Walking speed started at 0.5 km/hr and was ramped up in 0.5 km/hr increments to 3.0 km/hr as
tolerated
PT: General conditioning, range of motion exercise, activities of daily living training and gait training
Changes in medication not allowed. Participants who changed their medication were excluded
Outcomes UPDRS
UPDRS subscales (mental, ADL, motor and complications)
Gait speed
No. steps taken for 10 metre walk
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Eligibility Criteria Low risk Inclusion and exclusion criteria stated
Randomisation Method Unclear risk Method not stated
Concealment of Allocation High risk Envelope method used
Similarity at Baseline Low risk Group characteristics similar at baseline
Intention to Treat Analysis Unclear risk Analysed on an intention-to-treat basis
Withdrawals Described High risk Withdrawals at 17%
Cointerventions Constant Low risk Changes in medication not allowed. Participants
who changed their medication were excluded
Comparable arms Low risk Same time and attention given to participants in
both arms
Blinded Assessors High risk Assessors were not blinded
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Morris 2009
Methods Parallel group design
Randomised using generated random number sequences by an independent university source
Method of analysis not stated
Treated as inpatients for 2 weeks in 16 sessions each lasting 45 minutes
Assessed at baseline, immediately after treatment and at 3 months
Assessors were blinded
Participants 14 participants in movement strategies (MS) group and 14 in exercise (Ex) group. 2 participants missing
from follow-up in exercise group
Participants mean age 68 years (MS), 66 years (Ex); Male/female ratio, disease severity and duration
for groups were not stated
Inclusion criteria: Aged 21 -80 years, medically stable, diagnosis of IPD confirmed by a neurologist,
>23 MMSE with a minimum of 2 out of 3 on the recall question, Hoehn & Yahr II or III, able to walk
10 metres 3 times without assistance. Exclusion criteria: Unsafe to participate in the therapy programs
Interventions MS: Learn how to use cognitive strategies such as focusing their attention onmovement and responding
to external cues to enhance walking, turning, standing up from a chair and obstacle negotiation. Based
on principles of Victorian comprehensive Parkinson’s disease program
Ex: Lower limb and trunk strengthening exercises, spinal and lower limb flexibility exercises and re-
ceiving feedback on optimal postural alignment for a range positions
Not stated whether the drug therapy was constant during treatment
Outcomes UPDRS Motor
UPDRS ADL
10 m walk test
Timed up and go





Bias Authors’ judgement Support for judgement
Eligibility Criteria Low risk Inclusion and exclusion criteria stated
Randomisation Method Low risk Randomised using generated random number se-
quences by an independent university source
Concealment of Allocation Low risk Randomised using generated random number se-
quences by an independent university source
Similarity at Baseline Unclear risk Only average age of groups given
Intention to Treat Analysis Unclear risk Method of analysis not stated
Withdrawals Described Low risk Withdrawals at 7%
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Morris 2009 (Continued)
Cointerventions Constant Unclear risk Not stated whether the drug therapy was constant
during treatment
Comparable arms Low risk Same time and attention given to participants in
both arms
Blinded Assessors Low risk Assessors were blinded
Palmer 1986
Methods Parallel group design
Randomised in pairs matched for stage of disease, sex and age, method not stated
Method of analysis not stated
Treated as outpatients for 12 weeks in 1 hour sessions 3 times per week
Assessed at baseline and immediately after therapy
Assessors were blinded
Participants 7 participants in United Parkinson Foundation (UPF) exercise program, 7 in upper body karate (UBK)
training program. No dropouts were described
Participants mean age 63.9 years (UPF), 65.9 years (UBK); Male/female ratio not stated; Hoehn and
Yahr 2.4 (UPF), 2.4 (UBK); Duration of condition not stated
Inclusion criteria: IPD, stabilization on a regimen of pharmacologic therapy, ability to attend the
scheduled evaluation and exercise sessions. Exclusion criteria: Physical problems that might cause them
to risk injury during exercises
Interventions UPF: Stretch exercises from the UPF exercise program led by a corrective therapist
UBK: Trained in upper body Karate techniques by a rehabilitation nursing student who had a black
belt in karate. All karate was done in a seated position. Each session consisted of approximately 15 mins
warm-up stretching exercises, 35 mins karate training and 10 mins cool down stretching exercises
Drug therapy was stable during therapy period.
Outcomes Forearm pronation/supination rate
Pursuit score walk index
Degree of activated rigidity




Minnesota placing and turning test
Arm swings test
Rapid alternating arm movement test
Button board
Putting shirt on and off
Putting shoes and socks on and off
Getting up from chair
Long latency stretch response
Notes
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Palmer 1986 (Continued)
Risk of bias
Bias Authors’ judgement Support for judgement
Eligibility Criteria Low risk Inclusion and exclusion criteria stated
Randomisation Method Unclear risk Method not stated
Concealment of Allocation Unclear risk Randomisation method not stated
Similarity at Baseline Low risk Group characteristics similar at baseline
Intention to Treat Analysis Unclear risk Method of analysis not stated
Withdrawals Described Low risk No withdrawals
Cointerventions Constant Low risk Drug therapy was stable during therapy period
Comparable arms Low risk Same time and attention given to participants in
both arms
Blinded Assessors Low risk Assessors were blinded
Pelosin 2010
Methods Parallel group design
Randomised by computerised random-number generator performed by an independent researcher
Method of analysis not stated
Treated as outpatients for 4 weeks with hour long sessions delivered 3 times per week
Assessed at baseline, 2 days after completion of all therapy sessions and 4 weeks later
Assessors were blinded
Participants 9 participants in action group, 9 in landscape group. 2 additional patients were recruited but excluded
due to past history of neurological conditions other than PD. No dropouts described
Participants mean age 68.8 years (action), 70.2 years (landscape); Male/female ratio not stated; Hoehn
& Yahr 2.1 (action), 2.2 (landscape); Duration of condition 11.6 years (action), 9.5 years (landscape)
Inclusion criteria: IPD according to the UK PDS BB criteria. All on stable medication regime. Mobile
despite occurrence of freezing at least once a week (minimum score of 2 on item 3 of the FOG
questionnaire) and for at least 2s (minimum score of 1 on item 4 of FOG-Q). MMSE > 24. Exclusion
criteria not stated
Interventions Action: Instructed to carefully watch 6 video clips (each clip lasting 6 mins) showing strategies useful
in circumventing FOG episodes. During each training session 2 video clips (with different sequences
of actions) were presented twice. The complexity of movements progressively increased from simple
actions to more complex movements. All actions shown in the video clips were performed by a physical
therapist. To ensure proper attention during the video presentation, patients were explicitly asked to
concentrate on how the actions were performed and were not allowed to imitate any movement. After
video clip observation, patients were asked to practice (for the remaining time of the session-36 min)
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Pelosin 2010 (Continued)
the observed actions repetitively and accurately according to the instructions of the physical therapist
Landscape: Matched the experimental protocol, with the exception that during each training sessions
they watched 2 video clips (presented twice) containing sequences of static pictures of mountains and
seaside, countryside, and desert scenes without any living (human or animal) representations. During
training sessions, patients in the landscape group performed the same movements/ actions used for the
Action group following the physical therapist’s instructions, in the exact order and for the same amount
of time
Drug therapy was stable during trial period.
Outcomes FOG Questionnaire and FOG diary
Timed up and go
10 metre walking test
Tinetti scale part I and II
Berg balance scale
PDQ-39
Notes Only data for FOG could be extracted from paper
Risk of bias
Bias Authors’ judgement Support for judgement
Eligibility Criteria Low risk Inclusion criteria stated
Randomisation Method Low risk Randomised by computerised random-number
generator
Concealment of Allocation Low risk Randomisation performed by an independent re-
searcher
Similarity at Baseline Low risk Group characteristics similar at baseline
Intention to Treat Analysis Unclear risk Method of analysis not stated. ITT was not used
Withdrawals Described Low risk Withdrawals at 10%
Cointerventions Constant Low risk Drug therapy was stable during trial period
Comparable arms Low risk Same time and attention given to participants in
both arms
Blinded Assessors Low risk Assessors were blinded
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Picelli 2012
Methods Parallel group design
Participants randomised using list, generated by www.randomisation.com kept in locked desk draw
Analysed on a per protocol basis
Treated as outpatients for 45 minute sessions, 3 times per week for 4 weeks
Assessed at baseline, post intervention, and 1 month after treatment
Assessors were blinded
Participants 21 participants in Robot assisted gait-training group (RAGT) and 20 participants in physiotherapy
group (PT). 3 dropouts in RAGT group and 2 in PT group
Participants’ mean age 68.1 years (RAGT), 68.7 years (PT). Male/female ratio, 10/8 (RAGT), 6/12
(PT). Hoehn and Yahr 2.7 (RAGT), 2.7 (PT). Duration of PD 6.6 years (RAGT), 7.4 years (PT).
Baseline data not given for drop-outs
Inclusion criteria: Confirmed PD, Hoehn and Yahr score 2.5 or 3,MMSE score > 23. Exclusion criteria:
Severe dyskinesias of “on-off ” phases, change of PD medications during the study, deficits of somatic
sensation in the lower limbs, vestibular disorders or paroxysmal vertigo, other neurological orthopaedic
conditions involving the lower limbs and cardiovascular comorbidity
Interventions RAGT: 2 motor driven footplates positioned on 2 bars that provide a Robot assisted propulsion by
means of a planetary gear system, simulating stance and swing with a ratio of 60% to 40% between
the two phases. A progressive reduction of body weight combined with an increase in gait speed. Each
training session consisted of 3 parts (each one lasting 10 minutes), with a 5-minute rest after each of
them. Patients were first trained at 20% of body weight supported and at a speed of 1 km/h for 10
minutes; then at 10% of body weight supported and a speed of 1.3 km/hr for 10 mins; and finally, at
0% of body weight supported and a speed of 1.6 km/hr for 10 mins. Patients were instructed to “help”
the gait trainer (GT1) gait-like movement during training. Any patient unable to maintain the chosen
pace was excluded from the study
PT: Program included active joint mobilization and conventional gait training. Each treatment session
consisted of 2partswith a 5-minute rest between them. First patients performed active jointmobilization
of the lower limbs (hip, knee and ankle) in the supine and prone positions (10 repetitions of 6 exercises)
for 10 minutes (5 minutes per position). Then they performed conventional gait therapy based on the
proprioceptive neuromuscular facilitation (PNF) concept for 30 minutes. Among the PNF techniques
we facilitated pelvic motion to improve control of the pelvis as a “key point of control” for maintaining
a gait pattern. Conventional gait therapy consisted of 10 minutes each of rhythmic initiation, slow
reversal and agonistic reversal exercises applied to the pelvic region. The time spent in PNF was equal to
that spent in RAGT. The same trained therapist treated all the patients in this group and standardized
the duration of each part of the treatment
No changes in medications as this was a criterion for exclusion
Outcomes 10 m walk test
6 min walk test





Bias Authors’ judgement Support for judgement
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Picelli 2012 (Continued)
Eligibility Criteria Low risk Inclusion and exclusion criteria stated
Randomisation Method Low risk List generated using www.randomization.com
Concealment of Allocation High risk List kept by principal investigator
Similarity at Baseline Low risk No significant difference between groups
Intention to Treat Analysis Unclear risk Per protocol analysis used
Withdrawals Described High risk Withdrawals at 12%
Cointerventions Constant Low risk No changes in medications as this was a criterion
for exclusion
Comparable arms Low risk Same time and attention given to both groups
Blinded Assessors Low risk Assessors blinded
Poliakoff 2009
Methods Parallel group design
Randomisation method was done by drawing lots and placing allocations in two sets of sealed envelopes
for high and low severity of Parkinson’s disease
Method of analysis was unclear
Treatment delivered in two 1 hour sessions per week for 10 or 20 weeks
Assessed at baseline, at 10 weeks and 20 weeks
Assessors were not blinded
Participants 16 participants in 20 week gym group (gym), 16 in 10 week gym group (control). 4 dropouts from
gym group and 6 dropouts from control group
Participant mean age 66.6 years (gym), 63.7 years (control); Male/female ratio, 11/5 (gym), 10/6
(control); Hoehn and Yahr not stated; Duration of condition 7.4 years (gym), 4.7 years (control)
Inclusion criteria: mild to moderate PD. Exclusion criteria: diagnosed with dementia, attendance of a
group exercise class for Parkinson’s disease, other neurodegenerative disease, >2weeks holiday booked
during the study period
Interventions 20 Week: 20 week biweekly gym training programme at local leisure complex. 1 hours weekly training
in the studio and 1 hour in the gym, each run by gym staff with experience of working with PD. Gym
sessions consisted of mainly cardiovascular activity, studio sessions emphasised on gait and agility. The
patients used external stimuli (such as music) and team working was encouraged
10 Week: 10 week programme as above starting 10 weeks after baseline assessment
Not clear whether the drug therapy was constant during treatment




59Physiotherapy for Parkinson’s disease: a comparison of techniques (Review)
Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Poliakoff 2009 (Continued)
Illness perceptions (BIPQ)
Questionnaire assessing experiences of programme
Notes Abstract and manuscript accepted for publication in Neurorehabilitation
Data used from assessments at baseline and 20 weeks
Risk of bias
Bias Authors’ judgement Support for judgement
Eligibility Criteria Unclear risk Characteristics of included patients described but
not stated whether these items were used for the
selection of patients for trial
Randomisation Method High risk Drawing lots
Concealment of Allocation High risk Drawing lots
Similarity at Baseline Unclear risk Limited baseline data
Intention to Treat Analysis Unclear risk Attempted to assess all participants regardless of
whether they had started or completed interven-
tion. ITT not used
Withdrawals Described High risk Withdrawals at 31%
Cointerventions Constant Unclear risk Not clear whether the drug therapy was constant
during treatment
Comparable arms Unclear risk Half the amount of time and attention spent with
delayed start group
Blinded Assessors High risk Assessors were not blinded
Reuter 2011
Methods Parallel group design
Randomisation was conducted using a computer generated sequence
Method of analysis not stated
Treatment delivered in 70 minute sessions 3 times per week for 6 months
Assessed at baseline and post-intervention
Assessors were blinded
Participants 30 participants in Nordic walking group (NW), 30 in walking group (W) and 30 in flexibility and
relaxation group (FR). No dropouts from any group
Participant mean age 62.0 years (NW), 63.0 years (W), 62.1 years (FR); Male/female ratio not stated;
Hoehn & Yahr 2.5 (NW), 2.5 (W), 2.4 (FR); Duration of condition 5.3 years (NW), 6.0 years (W),
5.2 years (FR)
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Reuter 2011 (Continued)
Inclusion criteria: PD diagnosed using UKBB criteria assessed by movement disorder specialist, Hoehn
and Yahr stage II-III. Exclusion criteria: Severe concomitant disease which limit physical performance,
second neurological disease
Interventions NW: Consisted of warming up including some flexibility and strength exercises with and without the
poles. One session per week was dedicated to practising NW technique, the other sessions focused on
endurance training. Participants were encouraged to increase the intensity of the training by walking
faster or uphill and to increase the distance walked. Each training session finished with a cooling down
programme. Training sessions took place in a park and a forest near to the university hospital
W: Consisted of warming up, technique training, endurance training and cooling down. Instructors
emphasised on arm swing and coordination of upper and lower limbs. One session per week included
walking uphill to improve muscle strength
FR: Performed flexibility exercises and relaxation training. The training focused on stretching, improv-
ing balance and range of movements. The flexibility and relaxation programme did not include aerobic
exercises
Medical treatment was optimised prior to study and minor changes were allowed in 5 patients during
trial period
Outcomes Max walking speed on treadmill









Bias Authors’ judgement Support for judgement
Eligibility Criteria Low risk Inclusion and exclusion criteria stated
Randomisation Method Low risk Computer generated sequence
Concealment of Allocation Unclear risk Method not stated
Similarity at Baseline Low risk No significant difference in baseline demographic
data
Intention to Treat Analysis Unclear risk Analysis method not stated
Withdrawals Described Low risk No dropouts
Cointerventions Constant Unclear risk Minor changes in 5 patients
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Reuter 2011 (Continued)
Comparable arms Low risk Same time and attention given to participants in
both arms
Blinded Assessors Low risk Assessors were blinded
Ridgel 2009
Methods Parallel group design
Randomisation method not stated
Method of analysis not stated
Treatment delivered in 1 hour sessions, 3 times per week for 8 weeks
Assessed at baseline, immediately after completion of treatment, and four weeks after completion of
treatment
Assessors blinded for UPDRS outcome only
Participants 5 participants in forced exercise group, 5 in voluntary exercise. No dropouts described
Participants mean age 58 years (forced), 64 years (voluntary); Male/female ratio not stated; Hoehn and
Yahr stage not stated; Duration of condition 7.9 years (forced), 4.4 years (voluntary)
Inclusion criteria: IPD. Exclusion criteria not stated.
Interventions Forced: Tandem stationary bicycle with trainer. Lower extremity forced exercise (FE) intervention using
a stationary tandem bicycle. Patient’s pedaling rate was increased to approximately 30% more than
their preferred rate
Voluntary: Exercise on a stationary single bicycle.
Drug therapy was stable during trial period.
Outcomes UPDRS part III
Manual functional dexterity
Bimanual dexterity
Centre of pressure (CoP)
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Eligibility Criteria Unclear risk Criteria not stated
Randomisation Method Unclear risk Method not stated
Concealment of Allocation Unclear risk Method of randomisation not stated
Similarity at Baseline Unclear risk Hoehn and Yahr not stated
Intention to Treat Analysis Unclear risk Method of analysis not stated
Withdrawals Described Low risk Withdrawals at 10%
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Ridgel 2009 (Continued)
Cointerventions Constant Low risk Drug therapy was stable during trial period
Comparable arms Low risk Same time and attention given to participants in
both arms
Blinded Assessors High risk Assessors blinded for UPDRS outcome only
Robichaud 2012
Methods Parallel group design
Method of randomisation not stated
Method of analysis not stated
Treatment was delivered in 1 hour sessions twice per week for 24 months
Assessed at baseline, 6, 12, 18 and 24 months
Assessors were blinded
Participants Number randomised not stated. 48 patients assessed at 6 months, down to 38 at 24 months. Group
split not stated
Group baseline characteristics not stated. Total mean age 59 years, total mean duration of condition 7
years
Eligibility criteria not stated.
Interventions Progressive resistance exercise: Weight lifting program.
Fitness counts: Flexibility, balance and strengthening program
Not stated whether the drug therapy was constant during treatment
Outcomes UPDRS motor
Timed up and go
Berg balance scale
Modified physical performance test
Notes Abstracts and trial registrations only
Risk of bias
Bias Authors’ judgement Support for judgement
Eligibility Criteria Unclear risk Eligibility criteria not stated
Randomisation Method Unclear risk Method not stated
Concealment of Allocation Unclear risk Method of randomisation not stated
Similarity at Baseline Unclear risk Group baseline characteristics not stated
Intention to Treat Analysis Unclear risk Method of analysis not stated
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Robichaud 2012 (Continued)
Withdrawals Described High risk 21% lost between 6 and 24 months
Cointerventions Constant Unclear risk Not stated whether the drug therapy was constant
during treatment
Comparable arms Low risk Same time and attention given to both groups
Blinded Assessors Low risk Assessors blinded
Schenkman 2012a
Methods Parallel group design
Randomised using computer generated assignments kept in opaque, sealed envelopes, unsealed by
research assistant after baseline assessment
Analysed on an intention-to-treat basis
Treatment was delivered in 1 hour sessions, 3 times per week for the first 4 months then tapered for 1
month to once monthly sessions out to 16 months. Home exercise group received just once monthly
supervised sessions throughout
Assessed at baseline, 4 months, 10 months and 16 months
Assessors blinded
Participants 39 participants in Flexibilty/balance/function exercise group (FBF), 41 in Aerobic exercise group (AE)
and 41 in Home exercise group (HE)
Participant mean age 64.5 years (FBF), 63.4 years (AE), 66.3 years (HE); Male/female ratio 24/15
(FBF), 26/15 (AE), 26/15 (HE); Hoehn and Yahr 2.3 (FBF), 2.2 (AE), 2.3 (HE); Duration of condition
4.9 years (FBF), 3.9 years (AE), 4.5 years (HE)
Inclusion criteria: Primary PD diagnosed by amovement disorders specialist using theUKBBC, lived in
the community, ambulated independently, Hoehn& Yahr stage II-III. Exclusion criteria: Uncontrolled
hypertension, on-state freezing or exercise limitations from other disorders, MMSE<24
Interventions FBF: Individualised spinal and extremity flexibility exercises followed by group balance/functional
training. 2 months of flexibility training one-on-one with a physical therapist followed by 2 months of
small group exercise (up to 6 participants) that included flexibility, balance and functional exercise
AE: Treadmill, bike and/or elliptical trainer. Included 5-10 min of warm-up, 30 minutes exercise at
65% to 80% HR max and 5-10min of cool down. Participants were encouraged to use a treadmill but
were permitted to use a stationary bicycle or elliptical trainer
HE: Exercised at home using the National PD Foundation ‘Fitness counts’ program. Consisted of
exercises in the home setting utilizing Fitness Counts with a single monthly group exercise session
supervised by a physical therapist. Flexibility and strengthening exercises in sitting and standing. Daily
walking (no specific guidelines)
All participants regardless of group assignment were assisted to develop long term exercise habits. After
randomisation and before beginning to exercise, participantsmet with their trainer to discussmotivation
to exercise, potential barriers and strategies to develop exercise habits
Participants were asked to record supervised and home exercise throughout the 16 months
Drug therapy was kept constant for the first 4 months.
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Schenkman 2012a (Continued)
Outcomes Overall physical function
Balance - functional reach






Bias Authors’ judgement Support for judgement
Eligibility Criteria Low risk Inclusion and exclusion criteria stated
Randomisation Method Low risk Computer generated assignment
Concealment of Allocation High risk Sealed envelopes
Similarity at Baseline Low risk Group characteristics similar at baseline
Intention to Treat Analysis Unclear risk Intention-to-treat analysis used
Withdrawals Described High risk Withdrawals at 21%
Cointerventions Constant Unclear risk Drug therapy kept constant for first four months
only
Comparable arms Unclear risk HE group received less time and attention than
experimental groups
Blinded Assessors Low risk Assessors were blinded
Shankar 2009
Methods Parallel group design
Randomisation method not stated
Method of analysis not stated
Treatment was delivered in 30 min sessions, twice a week for 8 weeks
Assessed at baseline and at 2 months
Assessors were blinded
Participants 10 participants in Treadmill with Cueing (TwC) group, 9 in Treadmill without Cueing (T) group and
10 in Cueing only (C) group. No dropouts described
Baseline characteristics not stated for groups.
Inclusion criteria: Moderate Parkinson’s disease. No exclusion criteria
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Shankar 2009 (Continued)
Interventions TwC: Walking on the treadmill with music for 30 min twice a week. Music was selected based upon
participant input and cadence-matched to the participant’s preferred walking speed
T: Walking on the treadmill without music for 30 min twice a week
C: Listening to music for 30 min twice a week.
Not stated whether the drug therapy was constant during trial
Outcomes Gait and Balance Scale
UPDRS III
PDQ-39
Not stated when examinations took place
Notes Abstract only
Risk of bias
Bias Authors’ judgement Support for judgement
Eligibility Criteria Unclear risk Criteria not stated
Randomisation Method Unclear risk Method not stated
Concealment of Allocation Unclear risk Method of randomisation not stated
Similarity at Baseline Unclear risk Baseline characteristics not stated
Intention to Treat Analysis Unclear risk Method of analysis not stated
Withdrawals Described Unclear risk Withdrawals not described
Cointerventions Constant Unclear risk Not stated whether the drug therapy was constant
during trial
Comparable arms Low risk Same time and attention given to participants in
both T and TwC arms
Blinded Assessors Low risk Assessors were blinded
Shen 2011
Methods Parallel group design
Randomisation method not stated
Method of analysis not stated
Treatment delivered over 12 weeks
Assessed at baseline and immediately after training and at 12 weeks follow-up
Assessors were blinded
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Shen 2011 (Continued)
Participants 23 participants in balance group, 22 in control group. No dropouts described
Participants baseline characteristics not stated.
Inclusion criteria: PD patients. Exclusion criteria not stated
Interventions Balance: Task specific to facilitate reaction time and length of compensatory steps during activities with
self-induced perturbation and in response to external perturbation
Control: Strength training of lower limb muscles with moderate intensity
Not stated whether the drug therapy was constant during trial
Outcomes Limit of stability
Walking speed
One leg stance time




Bias Authors’ judgement Support for judgement
Eligibility Criteria Unclear risk Criteria not stated
Randomisation Method Unclear risk Method not stated
Concealment of Allocation Unclear risk Method of randomisation not stated
Similarity at Baseline Unclear risk Group characteristics not stated
Intention to Treat Analysis Unclear risk Method of analysis not stated
Withdrawals Described Unclear risk Withdrawals not described
Cointerventions Constant Unclear risk Not stated whether the drug therapy was constant
during trial
Comparable arms Low risk Same time and attention given to participants in
both arms
Blinded Assessors Low risk Assessors were blinded
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Shiba 1999
Methods Cross-over group design
Method of randomisation not stated
Method of analysis of the data not stated
Treated as outpatients for an unknown period of time. 1 week between each training regimen
Assessed at baseline and immediately after treatment
Not stated whether the assessors were blinded
Participants 8 participants took part in the study. No dropouts described
Baseline characteristics not stated for groups. Total mean age 65 years; total male/female ratio 3/5.
Inclusion criteria: Stable mild to moderate Parkinson’s disease. Exclusion criteria not stated
Interventions Visual training: Patients walked over parallel lines at 90 degrees to the direction of travel. Distance apart
of lines dependant on patients normal stride length
Auditory stimulation: Patients walked to a rhythm that was 30% of their comfortable walking rhythm.
Not stated whether the drug therapy was constant during trial
Outcomes Stride length
Notes Abstract only. No numerical data available
Risk of bias
Bias Authors’ judgement Support for judgement
Eligibility Criteria Unclear risk Criteria not stated
Randomisation Method Unclear risk Method not stated
Concealment of Allocation Unclear risk Method of randomisation not stated
Similarity at Baseline Unclear risk Baseline characteristics not stated
Intention to Treat Analysis Unclear risk Method of analysis not stated
Withdrawals Described Unclear risk Dropouts not described
Cointerventions Constant Unclear risk Not stated whether the drug therapy was constant
during trial
Comparable arms Unclear risk Treatment schedules not stated
Blinded Assessors Unclear risk Not stated whether the assessors were blinded
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Sigurgeirsson 2009
Methods Parallel group design
Method of randomisation not stated
Method of analysis not stated
Treatment delivered in 30 min sessions, 4 sessions per week for 4 weeks
Assessed at baseline, immediately after treatment and 3 months after treatment
Not stated whether the assessors were blinded
Participants 26 participants randomised, group split not stated. No dropouts described
Baseline characteristics of groups not stated.Total mean Hoehn Yahr 2.1
Inclusion and exclusion criteria not stated.
Interventions Exercise: Walking with visual cues.
Control: Walking without cues.
Not stated whether the drug therapy was constant during trial




Bias Authors’ judgement Support for judgement
Eligibility Criteria Unclear risk Criteria not stated
Randomisation Method Unclear risk Method not described
Concealment of Allocation Unclear risk Method of randomisation not described
Similarity at Baseline Unclear risk Baseline characteristics of groups not stated
Intention to Treat Analysis Unclear risk Method of analysis not stated
Withdrawals Described Unclear risk Withdrawals not described
Cointerventions Constant Unclear risk Not stated whether the drug therapy was constant
during trial
Comparable arms Unclear risk Same time and attention given to participants in
both arms
Blinded Assessors Unclear risk Not stated whether the assessors were blinded
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Smania 2010
Methods Parallel group design
Randomisation list used
Method of analysis not stated
Treated as outpatients in 50 min sessions, 3 times per week for 7 weeks
Assessed at baseline, immediately post treatment and 1 month post-treatment
Assessors were blinded
Participants 33 participants in balance group, 31 in control group. 5 dropouts in balance group, 4 in control group
Participants mean age 67.6 years (balance), 67.3 years (control); Male/female 14/14 (balance), 15/12
(control); Hoehn and Yahr not stated; Duration of condition 10.4 years (balance), 8.6 years (control)
Inclusion criteria: Idiopathic PD and postural instability, Hoehn & Yahr 3-4, did not require assistance
to rise fromchairs or beds. Exclusion criteria:Unstable cardiovascular disease or other chronic conditions
that could interfere with their safety during testing or training procedures, other neurological conditions
or mental deterioration (MMSE <23), severe dyskinesias or ‘on-off ’ phases
Interventions Balance: Each patient was submitted to balance training consisting of exercises aimed at improving both
feedforward and feedback postural reactions. Patients were required to repeat exercises from 3 different
groups. Group 1: self-destabilisation of the centre-of-body mass (feedforward), group 2 : externally
induced destabilisation of the centre-of-body mass (feedback), group 3: emphasis of coordination be-
tween leg and armmovements during walking as well as locomotor dexterity over an obstacle course and
other potentially destabilising activities (continuous feedback and feedforward adjustments). During
each session 10 exercises were undertaken, 4 from group 1, 4 from group 2 and 2 from group 3. 5 -
10 repeats of each for 5 mins. Complexity of exercises was increased with patient’s ability. Support was
provided by therapist at pelvis or chest when required
Control: Exercises not specifically designed to improve postural reactions. Active joint mobilisation,
muscle stretching and motor coordination exercises. During each session 10 exercises were undertaken,
6 in supine position, 2 in the sitting position and 2 in the standing position. 5 - 10 repeats of each for
5 mins. Complexity of exercises was increased with patient’s ability
Drug therapy was stable during trial period.
Outcomes Berg balance scale
Activities specific balance confidence
Postural transfer test
Self destabilization of the centre of foot pressure test
Falls diary
UPDRS Total




Bias Authors’ judgement Support for judgement
Eligibility Criteria Unclear risk Charateristics of included patients described but
not stated whether these items were used for the
selection of patients for trial
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Smania 2010 (Continued)
Randomisation Method Unclear risk Randomisation list used
Concealment of Allocation High risk Randomisation list kept in locked desk of principal
investigator
Similarity at Baseline Unclear risk Hoehn and Yahr scores not stated
Intention to Treat Analysis Unclear risk Method of analysis not stated
Withdrawals Described High risk Withdrawals at 14%
Cointerventions Constant Low risk Drug therapy was stable during trial period
Comparable arms Low risk Same time and attention given to participants in
both arms
Blinded Assessors Low risk Assessors were blinded
Talakkad 2011
Methods Parallel group design
Method of randomisation not stated
Method of analysis not described
Treated for 8 hours over 4 weeks
Assessed at baseline and after 4 weeks of intervention
Not stated whether assessors were blinded
Participants 60 participants were randomised into this trial. Dropouts were not described
Baseline characteristics of participants were not stated.
Eligibility criteria not stated.
Interventions Conventional gait training (CGT).
Partial weight supported treadmill training: 20% unweighting
Control: No specific intervention.
Drug therapy not described.
Outcomes Dynamic posturography
UPDRS (total and motor subscore)
Beat-to-beat finger blood pressure
Notes Abstract only
Control arm not included in this review
Risk of bias
Bias Authors’ judgement Support for judgement
Eligibility Criteria Unclear risk Eligibility criteria not stated
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Talakkad 2011 (Continued)
Randomisation Method Unclear risk Method of randomisation not stated
Concealment of Allocation Unclear risk Method of randomisation not stated
Similarity at Baseline Unclear risk Baseline characteristics not stated
Intention to Treat Analysis Unclear risk Method of analysis not described
Withdrawals Described Unclear risk Dropouts not described
Cointerventions Constant Unclear risk Drug therapy not described
Comparable arms Low risk Same time and attention given to participants in
both arms
Blinded Assessors Unclear risk Not stated whether assessors were blinded
Thaut 1996
Methods Parallel group design
Randomised using a computerised random number generator
Analysed on an intention-to-treat basis
Treated at home or in the community, for 10.5 hours over 3 weeks. Assessed in laboratory, at baseline
and immediately after treatment
Not stated whether assessors were blinded
Participants 15 patients in novel rhythmic auditory stimulation group (RAS), 11 in standard self paced training
group (SPT) and 11 in no treatment group (NT). No dropouts noted
Patients mean age 69 years (RAS), 74 years (SPT), 71 (NT); Male/female 10/5 (RAS), 8/3 (SPT), 8/3
(NT); Hoehn and Yahr 2.4 (RAS), 2.5 (SPT), 2.6 (NT); Duration of condition 7.2 years (RAS), 5.4
years (SPT), 8.5 years (NT).
Inclusion criteria: IPD with significant gait deficits but able to walk without physical assistance. Exclu-
sion criteria not stated
Interventions RAS: Individual. 30 min/day walking to 3 different tempos of music. For 1st week; normal tempo =
pretest cadence, quick = 5-10% faster, fast = an additional 5-10% faster. After each week each tempo
was increased by 5-10% to a maximum pace of 130 steps/min.
SPT: Individual. 30 min/day walking at normal, quick and fast speeds
NT: No treatment.




EMG analysis on leg muscles
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Thaut 1996 (Continued)
Notes 3 arms to trial; RAS, SPT and no treatment. SPT versus no treatment are compared in ’Physiotherapy for
patients with Parkinson’s disease’ Cochrane review. New correspondence with author on randomisation
method
Risk of bias
Bias Authors’ judgement Support for judgement
Eligibility Criteria Low risk Inclusion and exclusion criteria confirmedwith au-
thor correspondence
Randomisation Method Low risk Randomised using a computerised random num-
ber generator
Concealment of Allocation Unclear risk Method not stated
Similarity at Baseline Low risk Group characteristics similar at baseline
Intention to Treat Analysis Low risk Analysed on an intention-to-treat basis
Withdrawals Described Low risk No withdrawals
Cointerventions Constant Low risk Drug therapy was stable during trial period
Comparable arms Low risk Same time and attention given to participants in
both arms
Blinded Assessors Unclear risk Not stated whether assessors were blinded
Toole 2005
Methods Parallel group design
Randomised using table of random numbers
Method of analysis not stated
Treatment delivered in 20 mins sessions, 3 times per week for 6 weeks
Assessed at baseline, within 1 week of completing intervention and 4 weeks later
Not stated whether assessors were blinded
Participants 23 participants randomised, group split not stated. No dropouts described
Participants mean age 75.4 years standard treadmill group (ST), 76.4 years unweighted treadmill group
(UT), 72.0 years weighted treadmill group (WT); Male/female ratio not stated; Hoehn & Yahr 4.8
(ST), 3.6 (UT), 3.4 (WT); Duration of condition not stated
Inclusion criteria: Parkinsonism, Hoehn and Yahr 1-4. Exclusion criteria: Uncompensated cardiovas-
cular disease, uncontrolled high blood pressure, leg claudication, significant dementia, other disorders
of comprehension and/or other medical conditions that would interfere with the participants safety
and comfort during submaximal exercise
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Toole 2005 (Continued)
Interventions ST: Treadmill training with no loading or unloading.
UT: Treadmill training assisted by the biodex unweighting system at a 25% body weight reduction for
15 mins then 5 mins with system removed
WT: Treadmill training wearing weighted scuba-diving belt which increased normal body weight by
5% for 15 mins then 5 mins without belt
Not stated whether the drug therapy was constant during trial
Outcomes Balance from dynamic posturography
Berg balance scale
UPDRS




Bias Authors’ judgement Support for judgement
Eligibility Criteria Low risk Criteria stated
Randomisation Method Unclear risk Table of random numbers, unclear how generated
Concealment of Allocation Unclear risk Randomised using table of random numbers
Similarity at Baseline Low risk Group characteristics similar at baseline
Intention to Treat Analysis Unclear risk Method of analysis not stated
Withdrawals Described Unclear risk Withdrawals not described
Cointerventions Constant Unclear risk Not stated whether the drug therapy was constant
during trial
Comparable arms Low risk Same time and attention given to participants in
both arms
Blinded Assessors Unclear risk Not stated whether assessors were blinded
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Vivas 2011
Methods Parallel group design
Randomisation method not stated
Method of analysis not stated
Treated as outpatients with twice weekly 45 minute sessions for 4 weeks
Assessed at baseline, after 4 weeks treatment and at 17 days follow-up
Assessors were not blinded
Participants 6 participants in water based exercise group (Water), 6 in land based exercise group (Land). 1 dropout
in Water group
Participant mean age 65.7 years (Water), 68.3 years (Land); Male/female ratio 3/3 (Water), 4/2 (Land)
; Hoehn and Yahr 2.7 (Water), 2.4 (Land); Duration of condition 4.2 (Water), 7.8 (Land)
Inclusion criteria: IPD, ability to follow a stable medication schedule, Hoehn & Yahr stage II-III
(Off medication), lack of dementia (MMSE ≥ 24). Exclusion criteria: unable to walk independently,
undergone surgical treatment for PD
Interventions Water: Warm-up exercises, trunk mobility exercises, postural stability exercises, transferring oneself and
changing body positions, all carried out in water. Progression was encouraged with introduction of
more complex exercises as appropriate
Land: Warm-up exercises, trunk mobility exercises, postural stability exercises, transferring oneself and
changing body positions, all carried out on land. Progression was encouraged with introduction of more
complex exercises as appropriate
Medication withheld for 12 hours before evaluations, for OFF-dose performance
Outcomes Functional reach test
Berg balance scale
Gait - turn time, velocity, cadence, step amplitude




Bias Authors’ judgement Support for judgement
Eligibility Criteria Low risk Inclusion and exclusion criteria stated
Randomisation Method Unclear risk Method not stated
Concealment of Allocation Unclear risk Randomisation method not stated
Similarity at Baseline Low risk Group characteristics similar at baseline
Intention to Treat Analysis Unclear risk Analysis method not stated
Withdrawals Described Low risk Withdrawals at 8%
Cointerventions Constant Unclear risk Not stated whether the drug therapy was constant
during trial
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Vivas 2011 (Continued)
Comparable arms Low risk Same time and attention given to both groups
Blinded Assessors High risk Assessors not blinded
Werner 2010
Methods Parallel group design
Randomised by individual not involved in testing or treatment using a computer generated number
list for allocation
Analysed on an Intention-to-treat basis
Treatment delivered in 90 min sessions, 2 times per week for 2 weeks
Assessed at baseline (4-5 days prior to start of intervention), 1 week after training and at 3, 6 and 12
months
Assessors were blinded
Participants 6 participants in Verbal instruction with augmented feedback group (VIAF), 6 in Verbal instruction
only group (VI). 5 dropouts at follow-up time-points, group split not stated
Participant mean age 72.8 years (VIAF), 69.3 years (VI); Male/female ratio 5/1 (VIAF), 5/1 (VI);
Hoehn and Yahr 2.3 (VIAF), 2.5 (VI); Duration of condition not stated
Inclusion criteria: Adequate vision. Exclusion criteria: MMSE<21, marked dyskinesia or other neuro-
logical impairments in addition to PD. Cardiac or musculoskeletal pathology that might impact gait,
required an assistive device to walk, had video feedback or gait training previously or had difficulty
understanding English
Interventions VIAB: 15 trials, of walking 7.5 m then returning to starting position with instruction to ’Walk as well
as you can’, per session. Verbal instruction and augmented feedback before each trial and 3 minutes
of seated rest between each trial. Verbal instructions were to ’take big step’ prior to each trial, during
rest period participants were given 3 viewings of video playback of their walking performance from
prior trial. On each viewing they were asked to a) focus on step length and comment on what they
observed, b) indicate what they planned to do on next attempt. If subject did not comment accurately
after viewing video or did not verbalise what they planned to do next, additional verbal ’knowledge
of performance’ (KP) or suggestions/corrections (’transitional information’ (TI)) were provided by the
experimenter
VI: Trials conducted in same manner as for VIAB group but during rest period the group engaged in
discussion or were given something to read







Bias Authors’ judgement Support for judgement
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Werner 2010 (Continued)
Eligibility Criteria Low risk Inclusion and exclusion criteria stated
Randomisation Method Low risk Computer generated randomisation
Concealment of Allocation Low risk Randomised by individual not involved in testing
or treatment
Similarity at Baseline Low risk Group characteristics similar at baseline
Intention to Treat Analysis Low risk Analysed on an intention-to-treat basis
Withdrawals Described Low risk No withdrawals at post-intervention time point.
Withdrawals at 42% for follow up
Cointerventions Constant Low risk Drug therapy was stable during trial period
Comparable arms Low risk Same time and attention given to both groups
Blinded Assessors Low risk Assessors were blinded
Yang 2010
Methods Parallel group design
Randomised by independent arbiter who picked out a sealed envelopes 30 mins before the start of the
intervention
Method of analysis not stated
Treatment delivered in 30 mins sessions, 3 times per week for 4 weeks
Assessed at baseline, within 7 days of completion of treatment, 1 month after treatment
Assessors were not blinded
Participants 16 participants in downhill walking group (DW), 17 in physiotherapy group (PT). 2 dropouts in DW
group, 5 dropouts in PT group
Participants mean age 68.1 years (DW), 66.3 years (PT); Male/female 9/6 (DW), 7/8 (PT); Hoehn
and Yahr 2.2 (DW), 2.2 (PT); Duration of condition 4.8 years (DW), 5.3 years (PT)
Inclusion criteria: Diagnosed with IPD (as defined by the UK Brain Bank Criteria) by a neurologist,
Hoehn and Yahr stages I through III, ability to walk independently, stable medication usage, freedom
from any other problems that might affect training and ability to understand instructions and follow
commands. Exclusion criteria not stated
Interventions DW: Downhill walking training using a treadmill. Subjects walked on a motorized treadmill with a
body weight support (BWS) system under the close supervision of a physical therapist. Initially the
downhill grade was set at 3%. If subjects could walk with correct erect posture and large strides without
stumbling during the training period, the downhill grade was then increased by 1% per training period.
Treadmill speed was set at a level that was comfortable for each participant. A BWS of <40% of the
body weight was provided and decreased to the maximum extent possible. Rest periods were provided
as needed
PT:Conventional therapy training program consisted of flexibility exercises (5 mins), strengthening
exercises (7 mins), proprioceptive neuromuscular facilitation, coordination training, balance training
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Yang 2010 (Continued)
(8 mins) and overground walking training (10 mins)








Bias Authors’ judgement Support for judgement
Eligibility Criteria Low risk Inclusion criteria stated
Randomisation Method High risk Randomised by independent arbiter who picked
out a sealed envelopes
Concealment of Allocation High risk Randomised by sealed envelopes
Similarity at Baseline Low risk Group characteristics similar at baseline
Intention to Treat Analysis Unclear risk Method of analysis not stated
Withdrawals Described High risk Withdrawals at 21%
Cointerventions Constant Low risk Drug therapy was stable during trial period
Comparable arms Low risk Same time and attention given to participants in
both arms
Blinded Assessors High risk Assessors were not blinded
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Byl 2009 After contacting the author it was found that the study was not properly randomised
Cheon 2012 Not stated whether patients were randomised into trial. Author contacted but no response
Chouza 2011 Whole body vibration technique not usually used by physiotherapists
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(Continued)
Cianci 2010 Excluded as confounded due to use of rolling walker
Donovan 2011 Quasi randomised using alternate allocation
Farley 2005 Insufficient information available from abstract for review and no author correspondence was achieved
Filippin 2010 Single arm study, so not randomised trial
Frazzitta 2012 Comparator arm consists of suggested home exercise and usual care only
Gobbi 2009 Insufficient information available from abstract for review and not stated whether randomisation was carried
out
Haase 2011 Single short session of intervention; treatment under one day. Not rehabilitative therapy
Kamsma 1995 Partially randomised with a portion of patients placed in a convenient group based on practical grounds such
as availability of transport
Klassen 2007 Difference between the two physiotherapy arms is multidisciplinary education for which the physiotherapy
component is unknown
Knobl 2011 Not properly randomised, placed in groups
Lee 2011 Outcomes not relevant, stroke outcomes used and patients trained on one side of the body only
Ma 2009 Crossover trial carried out over one day only
Marchese 2000 Not properly randomised, pseudo-random number list used
Modugno 2010 Trial included a theatre training arm which could not be considered solely as physiotherapy
Munneke 2010 Randomised trial of systems of care for delivery of physiotherapy, not comparing different physiotherapy
techniques
Pacchetti 2000 Two arm trial included active music therapy arm, not considered to be solely physiotherapy intervention
Pohl 2003 Randomised multiple intervention cross-over, over 4 consecutive days. Randomisation was of the sequence
of the interventions, therefore not RCT
Rochester 2011 Excluded as the study was a randomised crossover over a couple of hours
Sage 2009a After contacting the author it was found that the study was not properly randomised
Sage 2009b After contacting the author it was found that the study was not properly randomised
Sage 2010 After contacting the author it was found that the study was not properly randomised
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(Continued)
Stallibrass 2001 The method of therapy used - Alexander Technique - is not used by physiotherapists. Therefore this trial was
excluded
Tamir 2007 Quasi-randomised trial using alternate allocation of patients to arms
Tickle-Degnen 2010 Multidisciplinary rehabilitation trail. Percentage component of physiotherapy was not specified, therefore
unable to differentiate the contribution of physiotherapy to any change in the outcome measures
Wulf 2009 Multiple cross-over trial over a short period of time
Yen 2011 No outcome measures relevant to our review
Characteristics of ongoing studies [ordered by study ID]
Brauer 2011
Trial name or title Single and dual task gait training in people with Parkinson’s disease: A protocol for a randomised controlled
trial
Methods Parallel group design
Randomised with opaque envelopes containing allocations from a computer generated random number
sequence prepared by offsite investigator not involved in recruitment, intervention or data collection
Analysed on an intention-to-treat basis
Treated as outpatients for 40 - 60 minutes session 3 times a week for 4 weeks, setting not stated
Assessed at baseline, immediately after treatment and after 6 months follow-up
Assessors blinded
Participants Planning to recruit 60 participants.
Inclusion criteria: 18 years or older, IPD diagnosed using UKBB criteria, able to walk 100 m independently
with or without gait aids, report reduced step length or slowed gait speed, confirmed by clinical examination,
Hoehn and Yahr stage I-IV. Exclusion criteria: Neurological condition other than PD, musculoskeletal or
cardiopulmonary conditions that affect the ability to safely walk, had surgery for PD such as deep brain
stimulation, score <24 on the mini-mental status examination
Interventions Single task training: One-to-one therapy sessions with therapist. Individually progressed program of gait
training aimed at improving step length via repeated practice of straight line walking, turning, obstacle
negotiation and challenging gait tasks such as increasing speed and altering surface challenges. External cues
to increase step length will be used when needed. Instructions will not be given while participant is walking to
avoid dual tasking. A home program will be incorporated at week 2 for 6 months, which includes a walking
program and a range of balance, strengthening and postural exercises
Dual task training: One-to-one therapy sessions with therapist. Aim to improve step length under dual task
conditions that is when concurrently performing added cognitive or motor tasks. Participants will undertake
repeated practice of walking aiming to improve step length using external cueing techniques including verbal,
visual or auditory approaches. Progressing to internal concurrent cueing of appropriate step length. The gait
tasks undertaken will be progressed from simple to more complex tasks as outlined for the single task group.
In addition a variety of added tasks will be progressively integrated into the training program. These include
tasks such as listening, speaking, conversing, generation of simple and complex lists, language, calculation
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Brauer 2011 (Continued)
and motor tasks increasing in complexity. Tasks will include those designed to reflect functional everyday
activities such as carrying bags, getting keys out of a pocket, counting money, recalling directions or making
a shopping list. Complexity will be progressively integrated as more complex tasks result in greater dual task
interference with gait in people with PD. If able, participants will be progressed to performing increasingly
complex cognitive tasks while concurrently walking. Motor tasks such as carrying and manipulation will also





Step length coefficient of variation
Double support time
Trail making A&B tests
Strop colour-word interference test
Digit span test
Timed up and go
6-minute walk test
Measures of community mobility questionnaire






Freezing of Gait questionnaire






Trial name or title Gait and step training to prevent falls in Parkinson’s disease
Methods Parallel group design
Treatment delivered for 1 hour per day, 3 times per week for 8 weeks
Assessed at baseline, at 8 weeks, at 1 month follow-up and 5 month follow-up
Assessors blinded
Participants Planning to recruit 90 participants.
Inclusion criteria: Diagnosis of PD, postural instability - gait disorder predominant PD, history of falls, gait
freezing or a positive pull test, stable regimen of medications, ability to stand and walk 3 m without assistance,
stage 2 or 3 of the Hoehn and Yahr disability scale and moderate or higher cognitive scores
81Physiotherapy for Parkinson’s disease: a comparison of techniques (Review)
Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Protas 2005 (Continued)
Interventions GSP: Gait and step perturbation. Gait training on a treadmill and in a safety harness while walking in four
directions: frontwards, backwards, left sideways and right sideways. Training will start with a treadmill speed
that is equivalent to fastest overground walking speed for forward walking and fastest possible for other
directions and will increase during training. This group will also receive step training while positioned in 4
directions consisting of suddenly turning the treadmill on/off. The subjects will be required to maintain their
balance during perturbations
SPT: Seated exercise. This group will receive seated active range of motion, and upper and lower extremity
aerobic training
Outcomes Usual and fastest gait speed
5-step test
UPDRS
Gait and balance scale
Center for Epidemiological Studies depression scale
Cognistat - a co-morbidity scale
Activities balance confidence
Physical activity scale for the elderly
Limits of stability
Falls frequency




Trial name or title Endurance exercise in Parkinson’s disease
Methods Parallel group design
Randomisation method not stated
Treatment was delivered four times a week for 6 months
Assessors were blinded
Participants Estimated total enrolment, 126 participants. Three arm trial: No intervention control group (NT), vigorous
exercise group (VE), moderate exercise group (ME)
Inclusion Criteria: Clinical diagnosis of primary Parkinson’s disease, in a Hoehn and Yahr stage less than stage
III, disease duration is less than 5 years, not likely to require dopaminergic therapy within 6 months.
Exclusion Criteria: Use of any PD medication within 60 days prior to the beginning the study, includ-
ing levodopa, direct dopamine agonists, amantadine, Rasagiline (Azilect), Selegiline (Eldepryl), Artane (tri-
hexyphenidyl). Duration of previous use of medications for PD that exceeds 90 days. Expected to require
dopaminergic therapy in the next 6 months. Poorly controlled or unstable cardiovascular disease. Uncon-
trolled hypertension. Hypo- or hyperthyroidism, abnormal liver function, abnormal renal function. Mild
cognitive impairment (Montreal Cognitive Assessment score<26/30). Depression that precludes ability to
exercise (Beck depression score>13). Disorders that interfere with ability to perform endurance exercises.
Regular participation in vigorous endurance exercise. Evidence of serious arrhythmias or ischemic heart dis-
ease. Any clinically significant medical condition, psychiatric condition, drug or alcohol abuse, or laboratory
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Schenkman 2012b (Continued)
abnormality that would, in the judgment of the investigators, interfere with the ability to participate in the
study
Interventions NT: Control Group. Wait listed to moderate or vigorous exercise after 6 months of no exercise
VE: Endurance exercise at 80-85% HR max.
ME: Endurance exercise at 60 - 65% HR max.
Outcomes Adherence to exercise
UPDRS Motor
Adverse events




Trial name or title Strength training and medication effects in Parkinson’s disease: effects on hypokinesia in Parkinson’s disease
Methods Treated for 12 weeks
Participants Inclusion criteria:Male or female at least 40 years of age, neurologist diagnosed idiopathic PD (usingUKBrain
Bank Criteria), ambulatory and medically cleared by their physician to participate in an exercise regimen,
clinical signs of hypokinesia or postural instability, Folstein Mini-Mental State Examination score > 23,
currently taking dopamine replacement medication
Exclusion criteria: Previous surgical management of PD (pallidotomy, DBS), motor fluctuations and/or
dyskinesias uncontrolled by medications, central nervous system disorder (other than PD), myopathic disease
(e.g. focal myopathy) that affects skeletal muscle structure/function rheumatological disease that has an effect
on muscle and/or mobility, unstable cardiovascular disease that limits exercise abilities, impaired knee flexion,
<90°, extreme claustrophobia (secondary to the inability to perform the MRI scans) regular (2-3 times/week)
aerobic or resistance exercise performed over the past 6 months





Starting date August 2007
Contact information sheldon.smith@hsc.utah.edu
Notes
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Uc 2010
Trial name or title Effects of aerobic exercise in Parkinson’s disease
Methods Assessors blinded
Participants 100 participants to be enrolled.
Inclusion criteria: Veteran or non-veteran, presence of all 3 cardinal features of Parkinson’s disease (resting
tremor, bradykinesia and rigidity) which must be asymmetrical, Hoehn & Yahr stage I-III, men or women
aged 50-80 capable of performing the planned exercise programs, intention to remain in the local area over
the study period, stable dopaminergic treatment regimen for at least 4 weeks prior to baseline without any
clinical need for medication adjustment at the time of screening
Exclusion criteria: Secondary parkinsonism, Parkinson-plus syndromes, MMSE score<24, participating in an
aerobic exercise program, an unstable dosage of drugs active in the central nervous system during the 60 days
before the baseline visit, participation in drug studies or the use of investigational drugs within 30 days before
screening, structural brain disease, active epilepsy, acute illness or active confounding medical, neurological
or musculoskeletal conditions, alcoholism or other forms of drug addiction, inability to complete the graded
exercise test, lack of medical clearance from our pulmonologist, intention to move or take > 1 month vacation
during the study period, contraindications to MRI or claustrophobia requiring sedation
Interventions Aerobic exercise in the form of brisk walking using different training formats, four arms: group/continuous,
group/interval, single/continuous and single/interval
Outcomes Cycle ergonometry




Lab results (ECG, biochemistry, CBC)
Tests for Parkinsonism and cognition
Questionnaires about quality of life, mood and activities of daily living




Trial name or title ParkFit study: A randomised controlled trial evaluating the effectiveness of amultifaceted behavioural program
to increase physical activity in Parkinson patients
Methods Parallel group design
Randomised assigned using minimisation algorithm
Treatment delivered over 2 years, offered a maximum of 35 sessions per year, each session lasting 30 mins
Assessed at baseline, at 6 months, 12 months 18 months and 24 months
Assessors were blinded
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van Nimwegen 2010 (Continued)
Participants 586 participants randomised, 299 in ParkFit group and 287 in ParkSafe group. No dropouts described
Baseline characteristics for groups not stated
Inclusion criteria: PD according to UKBB criteria, aged between 40 and 75 years, sedentary lifestyle (<3
times a week vigorous-intensity physical activity for <60 mins or <3 times a week moderate-intensity physical
activity for <150 mins), Hoehn & Yahr score ≤3. Exclusion criteria: Unclear diagnosis (no gratifying and
sustained response to dopaminergic therapy), MMSE score <24, unable to complete dutch questionnaires,
severe co-morbidity interfering with daily functioning, daily institutionalised care, deep brain surgery
Interventions Both interventions were delivered exclusively by experienced therapists who participate in the Dutch Parkin-
sonNet
ParkFit: Brochure provided, ParkFit, covering specific strategies to promote behavioural change. Physical
therapists serve as personal activity coaches who guide patients towards a more active lifestyle, during specific
coaching sessions. Patient and coach create activity goals in order to obtain the 6-month goals. Patients receive
a personal ambulatory monitor with automated visual feedback showing the amount of actually delivered
daily physical activity, recorded by a triaxial accelerometer. The ParkFit program also included a maximum of
19 physical therapy sessions in year 1 and 23 in year 2. Based on individual disabilities, therapist and patient
jointly formulate treatment aims based on the evidence-based guideline of physical therapy for PD
ParkSafe: Patients receive a brochure,ParkSafewith information about the benefits of physical therapy. Specific
emphasis is given to the importance of safetywhenperformingdaily activities. Patients receive an individualised
physical therapy program. Total of 35 sessions per year: 19 physiotherapy plus 16 coach sessions). Physical
therapist and patient jointly formulate the aims of the projected treatment plan, based on individual problems
and disabilities
Not stated whether the drug therapy was constant during trial
Outcomes Level of physical activity
6 minute walk test
PDQ-39
Starting date September 2008
Contact information m.munneke@neuro.umcn.nl
Notes Subgroup analysis of those who succeeded in increasing their activity levels versus those who didn’t, assessed
for disease progression and physical fitness
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D A T A A N D A N A L Y S E S
This review has no analyses.
A D D I T I O N A L T A B L E S
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A P P E N D I C E S
Appendix 1. Search strategies










#10. #7 or #8 or #9
#11. #1 and #6 and #10
The Cochrane Library and The Cochrane Controlled Trials Register (Wiley online library) (Issue 1, 2012).




#5. MeSH descriptor Physical Therapy (Speciality) explode all trees
#6. MeSH descriptor Physical Therapy Modalities explode all trees
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#7. physical therapy
#8. physiotherapy
#9. MeSH descriptor Exercise explode all trees
#10. exercise
#11. MeSH descriptor Rehabilitation explode all trees
#12. rehabilitation
#13. {or #5-#13}
#14. #4 and #13
MEDLINE (Ovid) 1966 - Jauary (Week 4) 2012.
1. randomized controlled trial.pt







9. 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8
10. exp animals/ not humans.sh.
11. 9 not 10
12. exp Parkinson Disease/
13. “parkinson*”.ab.ti.
14. 12 or 13




19. exercise*.mp. [mp=title, original title, abstract, name of substance word, subject heading word, unique identifier]
20. rehabilitation*.mp. [mp=title, original title, abstract, name of substance word, subject heading word, unique identifier]
21. 15 or 16 or 17 or 18 or 19 or 20
22. 11 and 14 and 21
23. limit 22 to yr=“2001 -Current”
EMBASE (Ovid) 1974 - January (Week 4) 2012.
1. random$.mp. [mp=title, abstract, subject headings, heading word, drug trade name, original title, device manufacturer name]
2. factorial$.mp. [mp=title, abstract, subject headings, heading word, drug trade name, original title, device manufacturer name]
3. (crossover$ or cross-over$).mp. [mp=title, abstract, subject headings, heading word, drug trade name, original title, device manu-
facturer name]
4. placebo$.mp. [mp=title, abstract, subject headings, heading word, drug trade name, original title, device manufacturer name]
5. (doubl$ adj blind$).mp. [mp=title, abstract, subject headings, heading word, drug trade name, original title, device manufacturer
name]
6. (singl$ adj blind$).mp. [mp=title, abstract, subject headings, heading word, drug trade name, original title, device manufacturer
name]
7. assign$.mp. [mp=title, abstract, subject headings, heading word, drug trade name, original title, device manufacturer name]
8. allocat$.mp. [mp=title, abstract, subject headings, heading word, drug trade name, original title, device manufacturer name]
9. volunteer$.mp. [mp=title, abstract, subject headings, heading word, drug trade name, original title, device manufacturer name]
10. crossover procedure.sh.
11. Double-blind Procedure.sh.
12. Randomized Controlled Trial.sh.
13. Single-blind Procedure.sh.
14. 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13
15. exp Parkinson Disease/
16. parkinson*.mp.
17. 15 or 16
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22. physiotherapy.mp. [mp=title, abstract, subject headings, heading word, drug trade name, original title, device manufacturer name]
23. exercise.mp. [mp=title, abstract, subject headings, heading word, drug trade name, original title, device manufacturer name]
24. rehabilitation.mp. [mp=title, abstract, subject headings, heading word, drug trade name, original title, device manufacturer name]
25. 18 or 19 or 20 or 21 or 22 or 23 or 24
26. 14 and 17 and 25
27. limit 26 to yr=“2001 - Current”
CINAHL (EBSCO) (1982-2012).
S1. (MH “Random Assignment”)
S2. (MH “Comparative Studies”)
S3. (MH “Clinical Research+”)
S4. (MH “Clinical Trials+”)
S5. (MH “Evaluation Research+”)
S6. TX ((control* or clinic* or prospective*) adj5 (trial* or study or studies))
S7. TX cross*over*




S12. (S1 or S2 or S3 or S4 or S5 or S6 or S7 or S8 or S9 or S10 or S11)
S13. (MH “Parkinson Disease”)
S14. “Parkinson*”
S15. “physiotherapy”
S16. (MH “Physical Therapy+”)
S17. (MH “Exercise+”)
S18. rehabilitation
S19. S13 or S14
S20. S15 or S16 or S17 or S18
S21. S12 and S19 and S20
ISI Web of Science: Science Citation Index Expanded (SCI-EXPANDED) (1981 to January 2012), ISI Web of Science: Confer-












#12. #11 OR #10 OR #9 OR #8 OR #7 OR #6 OR #5 OR #4 OR #3 OR #2 OR #1
#13. TS=(parkinson disease)
#14. TS=parkinson*





116Physiotherapy for Parkinson’s disease: a comparison of techniques (Review)
Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
#20. #19 OR #18 OR #17 OR #16
#21. #20 AND #15 AND #12
AMED (EBSCO) (1985-2012).
S1. (MH “Random Assignment”)
S2. (MH “Comparative Studies”)
S3. (MH “Clinical Research+”)
S4. (MH “Clinical Trials+”)
S5. (MH “Evaluation Research+”)
S6. TX ((control* or clinic* or prospective*) adj5 (trial* or study or studies))
S7. TX cross*over*




S12. (S1 or S2 or S3 or S4 or S5 or S6 or S7 or S8 or S9 or S10 or S11)
S13. (MH “Parkinson Disease”)
S14. “Parkinson*”
S15. “physiotherapy”
S16. (MH “Physical Therapy+”)
S17. (MH “Exercise+”)
S18. rehabilitation
S19. S13 or S14
S20. S15 or S16 or S17 or S18
S21. S12 and S19 and S20
REHABDATA (1995-2012). Searched using the term Parkinson*
REHADAT (1990 - 2012). Searched using the term Parkinson.
PEDro (1929-2012). Searched using the term Parkinson.
GEROLIT (1979-2012). Searched using the terms “parkinson*” AND “physi*”, “parkinson*” AND “exercise*”, “parkinson* AND
rehabilitation*”
LILACS (Virtual Health Library) (1982-2012); MedCarib (Virtual Health Library) (17th Century-2012); IMEMR (1984-
2012). Searched using the terms “Parkinson$” AND “physi$”, “Parkinson$” AND “exercise$”, “Parkinson$” AND “rehabilitat$”,
“Parkinson$” AND “physiotherap$”.
The Cochrane Controlled Trials Register. See the Cochrane Library.
The CentreWatch Clinical Trials listing service. Screened all entries under the Medical Condition ’Parkinson’s Disease’.
The metaRegister of Controlled Trial; NIDRR. Searched using the term Parkinson.
ClinicalTrials.gov. Searched using the terms “parkinson” AND “(physical therapy OR physiotherapy OR exercise OR rehabilitation)”.
RePORT. Searched using the terms “Parkinson” and “Rehabilitation”, “Parkinson” and “Exercise”, “Parkinson” and “Physical Therapy”,
“Parkinson” and “Physiotherapy”.
NRR.Searchedusing the terms “Parkinson” and “Exercise”, “Parkinson” and “Exercising”, “Parkinson” and “Physiotherapy”, “Parkinson”
and “Physiotherapies”, “Parkinson” and “Physical”, “Parkinson” and “rehabilitation”, “Parkinson” and “Rehabilitating”, “Parkinson”
and “Rehabilitate”.
Conference Proceedings Citation Index (1982-2012). See ISI Web of Science.
DISSABS (DISSertation ABStracts) (1999-2012). Search using the term “parkinson”.
Conference Papers Index (ProQuest) (1982-2012); Index to Theses (1970-2012); ProQuest dissertations and theses databases
(1861-2012).
Searched using the terms (all(Physical therapy*) OR all(physiotherap*) OR all(exercise) OR all(rehabilitation*)) AND all(parkinson*).
Electronic Theses Online Service (EThOS) (16th Century-2012). Searched using the terms “parkinson” AND “physical therapy”,
“parkinson” AND “physiotherapy”, “parkinson” AND “exercise”, “parkinson” AND “rehabilitation”.
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WH A T ’ S N E W
Last assessed as up-to-date: 31 January 2012.
Date Event Description
13 May 2014 New citation required but conclusions have not changed Conclusions not changed
13 May 2014 New search has been performed Search updated to 31 January 2012
New studies added, conclusions unchanged
H I S T O R Y
Protocol first published: Issue 4, 2000
Review first published: Issue 1, 2001
Date Event Description
29 November 2000 New citation required and conclusions have changed Substantive amendment
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of the review.
Carl Clarke contributed to the design of the protocol and was involved in the interpretation of the review providing clinical input.
Rebecca Stowe contributed to the design of the protocol and was involved in searching and selection of studies and interpretation of
the review.
Laila Shah was involved in searching and selection of studies for the review.
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